Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government
Veterans Benefits and Health Care About VA Find a VA Location

VA Health Systems Research

Go to the VA ORD website
Go to the QUERI website

Citations Database Search Results

Download these results to MS Excel

427 records found for:
Title = Opioid Use
Year =

  1. Hayes CJ, Raciborski RA, Acharya M, Noor NB, Nunes EV, Winhusen TJ. Evaluating the optimal duration of medication treatment for opioid use disorder. Addiction (Abingdon, England). 2026 Jan 7 DOI: 10.1111/add.70211.
  2. Roy PJ, Colvin R, Nickel KB, Ross RK, Durkin MJ, Suda KJ, Atkinson A, Butler AM. Impact of study design decisions on identification of treatment initiators of medications for opioid use disorder. Addiction (Abingdon, England). 2025 Dec 14 DOI: 10.1111/add.70288.
  3. Borsari B, Baxley C, Ladd BO, Delacruz J, Jackson KM, Fetterling T, Self KJ, Hassanbeigi Daryani S, Seal KH, Manuel JK. Adaptation of the Motivational Interviewing Skills Code to Identify Client Language Predicting Reduced Opioid Use Risk and Increased Use of Alternative Pain Care Strategies in Veterans. Methods and protocols. 2025 Dec 8; 8(6):DOI: 10.3390/mps8060149.
  4. Smith JJ, Noonan M, Johnson CE, Humphreys K, Gupta R. Potential health impacts of comprehensive access to opioid use disorder treatment in United States correctional facilities: A synthetic analysis. Addiction (Abingdon, England). 2025 Nov 3 DOI: 10.1111/add.70170.
  5. Mayrer BM, Sabol RM, Shuey B, Roy PJ, Suda KJ, Park TW, Anderson TS. Trends in Initiation of Buprenorphine for Opioid Use Disorder Among Older Adults. Journal of the American Geriatrics Society. 2025 Oct 25 DOI: 10.1111/jgs.70182.
  6. Fortney JC, Ratzliff AD, Blanchard BE, Ferro L, Chase E, Rouvere J, Duncan MH, Merrill JO, Simpson T, Williams EC, Austin EJ, Curran GM, Schoenbaum M, Heagerty PJ, Saxon AJ. Collaborative Care for Opioid Use Disorder in Primary Care: A Hybrid Type 2 Cluster Randomized Clinical Trial. JAMA psychiatry. 2025 Oct 1; 82(10):956-966, DOI: 10.1001/jamapsychiatry.2025.2126.
  7. Naderalvojoud B, Curtin C, Asch SM, Humphreys K, Hernandez-Boussard T. Evaluating the impact of data biases on algorithmic fairness and clinical utility of machine learning models for prolonged opioid use prediction. JAMIA open. 2025 Oct 1; 8(5):ooaf115, DOI: 10.1093/jamiaopen/ooaf115.
  8. Bicket MC, Qi X, Buchwalder K, Chua KP, Lagisetty P, Gunaseelan V, Waljee JF, Brummett CM, Li Y, Nguyen T. Trends in Use of Medications for Opioid Use Disorder among Commercially Insured U.S. Surgical Patients, 2016-2022. Anesthesiology. 2025 Sep 25 DOI: 10.1097/ALN.0000000000005771.
  9. Nateghi Haredasht F, Lopez I, Tate S, Ashtari P, Chan MM, Kulkarni D, Chen CA, Vangala M, Griffith K, Bunning B, Miner AS, Hernandez-Boussard T, Humphreys K, Lembke A, Vance LA, Chen JH. Predicting treatment retention in medication for opioid use disorder: a machine learning approach using NLP and LLM-derived clinical features. Journal of the American Medical Informatics Association : JAMIA. 2025 Sep 22 DOI: 10.1093/jamia/ocaf157.
  10. Ilgen M, Blow F, Piette JD, Goldstick J, Lewis M, Priest W, Matharu H, Bourgoise M, Young C, Ashe D, Price A, Lin LA. The psychosocial pain management to improve opioid use disorder treatment outcomes study: Protocol for a randomized controlled trial. Contemporary clinical trials. 2025 Sep 17; 158:108081, DOI: 10.1016/j.cct.2025.108081.
  11. Schapira MM, Chhatre S, Dow PM, Leonard CE, Groeneveld P, Prigge JM, Roberts C, Meisel ZF, Parikh RB, Jayadevappa R, Paulson EC, Krouse RS, Suda KJ, Kumar P, Muluk V, Hubbard RA. The impact of opioid use associated with curative-intent cancer surgery on safe opioid prescribing practice among veterans: An observational study. Cancer. 2025 Sep 15; 131(18):e70009, DOI: 10.1002/cncr.70009.
  12. Graham LA, Illarmo S, Wren SM, Mudumbai SC, Odden MC. Optimal multimodal analgesia combinations to reduce pain and opioid use following non-cardiac surgery: an instrumental variable analysis. Regional Anesthesia and Pain Medicine. 2025 Jul 17 DOI: 10.1136/rapm-2025-106720.
  13. Haskins C, Amspoker AB, Walder A, Hogan J, Ecker A, Lindsay J, Shore J. Telehealth Buprenorphine Initiation for Opioid Use Disorder Among American Indian and Alaska Native Veterans, April 2017-March 2023. Telemedicine journal and e-health : the official journal of the American Telemedicine Association. 2025 Jul 10 DOI: 10.1089/tmj.2025.0038.
  14. Krause JS, Dismuke-Greer CE, Grant B. The relationship of resilience with prescription opioid use and misuse among people with spinal cord injury. Rehabilitation Psychology. 2025 Jul 3 DOI: 10.1037/rep0000628.
  15. Jones KF, Mandavia AD, Gurewich D, Wyse JJ, Sung ML, Becker WC, Livingston NA. Characteristics of Veterans Receiving Medication for Opioid Use Disorder: An Observational Cohort Study. Journal of general internal medicine. 2025 Nov 1; 40(14):3452-3455, DOI: 10.1007/s11606-025-09657-6.
  16. Mandavia AD, Fonda JR, Banducci AN, Ameral VE, Sistad Hall RE, Loeffel LB, Roth CE, Simpson TL. Sex and race-ethnicity influences on opioid overdose deaths among veterans diagnosed with opioid use disorder between 2016 and 2021. Drug and Alcohol Dependence. 2025 Sep 1; 274:112764, DOI: 10.1016/j.drugalcdep.2025.112764.
  17. Ritter AZ, Roma C, Soske J, Merrick C, Kennedy KA, Nishar S, Kimmel S, Zullo AR, Dow PM. Optimizing care transitions to post-acute care following hospitalization for people with opioid use disorder. Innovation in aging. 2025 Aug 1; 9(8):igaf069, DOI: 10.1093/geroni/igaf069.
  18. Rostam-Abadi Y, Liebschutz JM, Subramaniam G, Stone R, Appleton N, Mazel S, Alexander K, Brill SB, Case A, Gelberg L, Gordon AJ, Hong H, Incze MA, Kawasaki SS, Kim T, Kline M, Lovejoy TI, McCormack J, Zhang S, McNeely J. Understanding the characteristics and comorbidities of primary care patients with risky opioid use: Baseline data from the multi-site "Subthreshold Opioid Use Disorder Prevention" (STOP) Trial. Journal of general internal medicine. 2025 Jun 2 DOI: 10.1007/s11606-025-09613-4.
  19. Shuman CJ, Zhang X, Hall SV, Tilea A, Clark SJ, Vance AJ, Courant A, Zivin K. Relationship between opioid use disorder during pregnancy, delivery-related outcomes, and healthcare utilization in Michigan Medicaid, 2012-2021. Journal of substance use and addiction treatment. 2025 Aug 1; 175:209720, DOI: 10.1016/j.josat.2025.209720.
  20. Nguyen T, Jiao Y, Lee SS, Lagisetty P, Bohnert A, Kocher KE, Chua KP. Medicaid Patients With ED Visits For Overdose: Disparities In Initiation Of Medications For Opioid Use Disorder. Health affairs (Project Hope). 2025 May 1; 44(5):622-630, DOI: 10.1377/hlthaff.2024.00984.
  21. Lott A, Danner AN, Malte CA, Salameh HA, Bachowski D, Gordon AJ, Hagedorn HJ, Frost MC, Williams EC, Saxon AJ, Trim RS, Hawkins EJ. Implementing buprenorphine for opioid use disorder in veterans health administration primary care: a qualitative analysis. Addiction science & clinical practice. 2025 Apr 30; 20(1):38, DOI: 10.1186/s13722-025-00568-9.
  22. Finlay AK, Pivovarova E, Yu M, Timko C, Binswanger IA, Smelson D, Taylor E, Harris AHS. Receipt of medications for opioid use disorders among veterans by race/ethnicity and legal involvement: an observational study of electronic health records. Health & justice. 2025 Apr 29; 13(1):28, DOI: 10.1186/s40352-025-00336-6.
  23. Xue L, Yin R, Cole ES, Lo-Ciganic WH, Gellad WF, Donohue J, Tang L. Development and evaluation of a machine learning model to predict acute care for opioid use disorder among Medicaid enrollees engaged in a community-based treatment program. Addiction (Abingdon, England). 2025 Apr 29 DOI: 10.1111/add.70079.
  24. Esmaeili A, Hagedorn HJ, Garcia CC, Bangerter A, Gustavson AM, Kenny ME, Miller W, Ackland PE, Clothier BA, Noorbaloochi S, Gordon AJ, Bounthavong M. Healthcare Expenditures Associated With Implementing an External Facilitation Program to Increase the Prescribing of Medications Used for the Treatment of Opioid Use Disorder Among Veterans. Substance use & addiction journal. 2025 Oct 1; 46(4):901-912, DOI: 10.1177/29767342251336035.
  25. Austin EJ, Bentley MJ, Ferro L, Saxon AJ, Fortney JC, Curran GM, Blanchard BE, Moghimi Y, Williams EC, Ratzliff AD, Ruiz MS, Koch U. Experiences of Team Collaboration in Primary Care-Based Delivery of Opioid Use Disorder Treatment. The journal of behavioral health services & research. 2025 Oct 1; 52(4):560-572, DOI: 10.1007/s11414-025-09946-2.
  26. Bozoghlian MF, Wilkinson B, Hadlandsmyth K, Glass N, Nepola JV, Patterson BM. Preoperative education on pain self-management and opioid consumption does not significantly impact opioid use and disposal following shoulder arthroplasty: results of a prospective randomized controlled trial. JSES international. 2025 Jul 1; 9(4):1274-1281, DOI: 10.1016/j.jseint.2025.03.010.
  27. Dixit AA, Lagisetty PA, Odden MC, Bicket MC, Humphreys KR, Mackey SC, Sun EC. Association Between Opioid Use Disorder and Healthcare Spending and Utilization in Emergency Surgical Patients: A Retrospective Analysis Using Commercial Claims. Annals of surgery open : perspectives of surgical history, education, and clinical approaches. 2025 Jun 1; 6(2):e568, DOI: 10.1097/AS9.0000000000000568.
  28. Becker WC, Seal KH, Nelson DB, DeRonne BM, Kats AM, Morasco BJ, Frank JW, Makris UE, Painter JT, Allen KD, Mixon AS, Bohnert A, Reznik TE, Hagedorn HJ, Hammett P, Borsari B, Baxley C, Krebs EE, VOICE Study Group. Buprenorphine, Pain, and Opioid Use in Patients Taking High-Dose Long-Term Opioids: A Randomized Clinical Trial. JAMA internal medicine. 2025 Apr 1; 185(4):372-381, DOI: 10.1001/jamainternmed.2024.8361.
  29. Baylis JD, Jorgenson TL, Pals HE, Hwang CS, Colvard MD, Alliu V, Moore T, Lin LA, Wyse J, Hawkins EJ, Hagedorn HJ, Gordon AJ. Clinical pharmacist practitioners prescribing of buprenorphine for opioid use disorder. Drug and Alcohol Dependence. 2025 Jun 1; 271:112663, DOI: 10.1016/j.drugalcdep.2025.112663.
  30. Frost MC, Malte CA, Kennedy AJ, Saxon AJ, Gordon AJ, Hagedorn HJ, Williams EC, Trim RS, Lott A, Danner AN, Hawkins EJ. Impact of an opioid use disorder medication implementation intervention on hospitalization and emergency department utilization in the Veterans Health Administration. BMC psychiatry. 2025 Mar 26; 25(1):288, DOI: 10.1186/s12888-025-06722-6.
  31. Buonora MJ, Mackey K, Khalid L, Hickey TR, Grimshaw AA, Moss M, Starrels JL, Alford DP, Becker WC, Weimer MB. Acute Pain Management in People With Opioid Use Disorder : A Systematic Review. Annals of internal medicine. 2025 Apr 1; 178(4):558-570, DOI: 10.7326/ANNALS-24-01917.
  32. Scorsone KL, Nunnery MA, Calder S, Danner A, Hawkins EJ, Gordon AJ, Frank JW. Insights Into Recovery: A Qualitative Analysis of Primary Care Provider Perspectives on Treating Veterans With Opioid Use Disorder in the VA Primary Care Setting. Substance use & addiction journal. 2025 Jul 1; 46(3):633-642, DOI: 10.1177/29767342251320450.
  33. Bin Noor N, Pro G, Acharya M, Eswaran H, Hayes CJ. Association between different modalities of opioid use disorder-related care delivery and opioid use disorder-related patient outcomes: A retrospective cohort study. Addictive behaviors reports. 2025 Jun 1; 21:100588.
  34. Ganz DA, Lai J, Cantor JH, Agniel D, Simon K, Stein BD, Taylor EA. Medications for opioid use disorder in traditional medicare beneficiaries: associations with age. Health Affairs Scholar. 2025 Feb 1; 3(2):qxaf036, DOI: 10.1093/haschl/qxaf036.
  35. Auty SG, Frakt AB, Shafer PR, Stein MD, Gordon SH. Severe Maternal Morbidity Among Pregnant People With Opioid Use Disorder Enrolled in Medicaid. JAMA Network Open. 2025 Jan 2; 8(1):e2453303, DOI: 10.1001/jamanetworkopen.2024.53303.
  36. Reynolds OC, Carlson KF, Gordon AJ, Handley RL, Morasco BJ, Korthuis TP, Lovejoy TI, Wyse JJ. Receipt of medications for opioid use disorder among rural and urban veterans health administration patients. Drug and Alcohol Dependence Reports. 2025 Mar 1; 14(0):100311, DOI: 10.1016/j.dadr.2024.100311.
  37. Szczygiel LA, Hosea F, Kocher KE, Dahlem CH, Dora-Laskey A, Bicket MC, Waljee J, Byrnes ME. "Doing the best we can": Qualitative study of clinician experiences with opioid use disorder care in emergency departments. The American journal of emergency medicine. 2025 May 1; 91:195-197, DOI: 10.1016/j.ajem.2024.11.067.
  38. Vakkalanka JP, Lund BC, Arndt S, Carter KD, Carnahan R. The Association Between Telehealth Use During Buprenorphine Treatment for Opioid Use Disorder and Clinical Outcomes: A Retrospective Cohort Study. Telemedicine journal and e-health : the official journal of the American Telemedicine Association. 2024 Nov 25.
  39. Sung ML, León C, Reisman JI, Gordon KS, Kerns RD, Li W, Liu W, Mitra A, Yu H, Becker WC. Disparities in Receipt of Medications for Opioid Use Disorder Before and During the COVID-19 Pandemic in the US Veterans Health Administration. Substance use & addiction journal. 2025 Apr 1; 46(2):369-376, DOI: 10.1177/29767342241293334.
  40. Hall OT, Lagisetty P, Rausch J, Entrup P, Deaner M, Harte SE, Williams DA, Hassett AL, Clauw DJ. Fibromyalgia is associated with increased odds of prior pain-precipitated relapse among non-treatment-seeking individuals with opioid use disorder. Annals of Medicine. 2024 Dec 1; 56(1):2422050.
  41. Livingston NA, Mandavia AD, Banducci AN, Loeffel LB, Sistad Hall R, Maloney M, Roth CE, Fonda JR, Davenport M, Meng F, Hyde J, Stein M. Emergency Department Visits, Inpatient Hospitalizations, and Nonfatal and Fatal Drug Overdoses During COVID-19 Among Veterans With Opioid Use Disorder. Journal of studies on alcohol and drugs. 2025 Jul 1; 86(4):582-589, DOI: 10.15288/jsad.24-00184.
  42. Moriates C, Boulton A, Bottner R, Weems J, Christian N, Bazajou T, Olmos DI, Bolton CD, Karns-Wright TE, Lanham HJ, Finley EP, Potter JS. The Support Hospital Opioid Use Disorder Treatment (SHOUT) Texas program implementation strategy for expanding treatment for hospitalized adults with opioid use disorder. Journal of substance use and addiction treatment. 2024 Oct 10; 209539.
  43. Seewald L, Bonar E, Bohnert ASB, Carter PM, King CA, Losman ED, Bacon L, Wheeler T, Walton M. Lifetime non-fatal overdose experiences among at-risk adolescents and young adults in the emergency department with past-year opioid use in the USA. Injury Prevention : Journal of The International Society For Child and Adolescent Injury Prevention. 2024 Oct 1; 30(5):373-380.
  44. Garcia-Vassallo G, Quinn NB, Moore BA, Chaudhry S, Moore DT, Sorenson ST, Braddock S, Edens EL. National Addiction Workshop: A Virtual Adaptation to Support Competency Development in Opioid Use Disorder Management. Substance use & addiction journal. 2024 Sep 19; 29767342241273423.
  45. Taylor E, Gray C, Stimmel M, Binswanger IA, Morse E, Timko C, Harris AHS, Smelson D, Finlay AK. Influences of the criminal justice system on use of medications for opioid use disorder: a qualitative study. BMC global and public health. 2024 Sep 19; 2(1):64.
  46. DiPiro ND, Dismuke-Greer CE, Krause JS. Self-reported benzodiazepine use among adults with chronic spinal cord injury in the southeastern USA: associations with demographic, injury, and opioid use characteristics. Spinal Cord. 2024 Nov 1; 62(11):667-673.
  47. Shearer R, Hagedorn H, Englander H, Siegler T, Kibben R, Fawole A, Patten A, Fitzpatrick A, Laes J, Fernando J, Appleton N, Oot E, Titus H, Krawczyk N, Weinstein Z, McNeely J, Baukol P, Ghitza U, Gustafson D, Bart G, Bazzi A. Barriers and facilitators to implementing treatment for opioid use disorder in community hospitals. Journal of substance use and addiction treatment. 2024 Sep 10; 167:209520.
  48. Oberman RS, Huynh AK, Cummings K, Resnick A, Taylor SL, Bergman AA, Chang ET. Engaging healthcare teams to increase access to medications for opioid use disorder. Health services research. 2024 Dec 1; 59 Suppl 2(Suppl 2):e14371.
  49. Hayes CJ, Raciborski RA, Nowak M, Acharya M, Nunes EV, Winhusen TJ. Medications for opioid use disorder: Predictors of early discontinuation and reduction of overdose risk in US military veterans by medication type. Addiction (Abingdon, England). 2024 Sep 7.
  50. Aalsma MC, Bell LA, Schwartz K, Ouyang F, Kolak M, Monahan PO, Mermelstein SP, Carson I, Hulvershorn LA, Adams ZW. Clinician Willingness to Prescribe Medications for Opioid Use Disorder to Adolescents in Indiana. JAMA Network Open. 2024 Sep 3; 7(9):e2435416.
  51. Howell BA, Lin LA, Coughlin LN. Treatment for Co-Occurring Stimulant and Opioid Use Disorders: Overcoming Barriers in the Era of Polysubstance Use. [Editorial]. JAMA psychiatry. 2024 Sep 1; 81(9):853-854.
  52. Park TW, Shuey B, Liebschutz J, Cantor J, Anderson TS. Treatment Approaches for Opioid Use Disorder Offered in US Substance Use Treatment Facilities. JAMA. 2024 Aug 13; 332(6):502-504.
  53. Austin EJ, Chen J, Soyer E, Idrisov B, Briggs ES, Ferro L, Saxon AJ, Fortney JC, Curran GM, Moghimi Y, Blanchard BE, Williams EC, Ratzliff AD, Ruiz MS, Koch U. Optimizing Patient Engagement in Treatment for Opioid Use Disorder: Primary Care Team Perspectives on Influencing Factors. Journal of general internal medicine. 2024 Jul 29.
  54. Hayes CJ, Martin BC, Hoggatt KJ, Cucciare MA, Hudson TJ, Gordon AJ. Average Daily Dose Trajectories for Episodes of Buprenorphine Treatment for Opioid Use Disorder. Substance use & addiction journal. 2024 Oct 1; 45(4):727-735.
  55. Austin EJ, Chen J, Soyer E, Idrisov B, Briggs ES, Moghimi Y, Saxon AJ, Fortney JC, Blanchard BE, Williams EC, Ratzliff AD, Ruiz MS, Koch U. Primary care team perspectives on approaches to engaging patients in treatment for opioid use disorder. Journal of substance use and addiction treatment. 2024 Oct 1; 165:209456.
  56. Hayes CJ, Raciborski RA, Martin BC, Gordon AJ, Hudson TJ, Brown CC, Pro G, Cucciare MA. Are gaps in rates of retention on buprenorphine for treatment of opioid use disorder closing among veterans across different races and ethnicities? A retrospective cohort study. Journal of substance use and addiction treatment. 2024 Jul 25; 209461.
  57. Wyse JJ, Eckhardt A, Newell S, Gordon AJ, Morasco BJ, Carlson K, Korthuis PT, Ono SS, Lovejoy TI. Integrating Buprenorphine for Opioid Use Disorder into Rural, Primary Care Settings. Journal of general internal medicine. 2024 Sep 1; 39(12):2142-2149.
  58. Williams EC, Matson TE, Hallgren KA, Oliver M, Wang X, Bradley KA. Assessing Substance Use Disorder Symptoms with a Checklist among Primary Care Patients with Opioid Use Disorder and/or Long-Term Opioid Treatment: An Observational Study. Journal of general internal medicine. 2024 Jul 1.
  59. J Hayes C, Bin Noor N, Raciborski RA, C Martin B, J Gordon A, J Hoggatt K, Hudson T, A Cucciare M. Development and validation of machine-learning algorithms predicting retention, overdoses, and all-cause mortality among US military veterans treated with buprenorphine for opioid use disorder. Journal of addictive diseases. 2024 Jun 30; 1-18.
  60. Couch JV, Whitcomb M, Buchheit BM, Dorr DA, Malinoski DJ, Korthuis PT, Ono SS, Levander XA. Patient perceptions of and experiences with stigma using telehealth for opioid use disorder treatment: a qualitative analysis. Harm reduction journal. 2024 Jun 27; 21(1):125.
  61. Frost MC, Coughlin LN, Zhang L, Lin LA. Comparison of Treatment Receipt and Hospitalization Among Patients With Stimulant Use Disorder and/or Opioid Use Disorder in the Veterans Health Administration. Journal of addiction medicine. 2024 Sep 1; 18(5):561-566.
  62. Jaffe K, Patel S, Chen L, Slat S, Bohnert A, Lagisetty P. Impact of Perceived Access and Treatment Knowledge on Medication Preferences for Opioid Use Disorder. Substance use & addiction journal. 2024 Oct 1; 45(4):706-715, DOI: 10.1177/29767342241254591.
  63. Eckhardt A, Waller DE, Shull S, Lovejoy TI, Morasco BJ, Gordon AJ, Wyse JJ. "They Ask Questions, But They Don't Want the Answers"-Perceptions of Clinical Communication Among Veterans Discontinuing Buprenorphine for the Treatment of Opioid Use Disorder. Substance use & addiction journal. 2024 May 20; 29767342241251761.
  64. Jaffe K, Slat S, Chen L, Macleod C, Bohnert A, Lagisetty P. Perceptions around medications for opioid use disorder among a diverse sample of U.S. adults. [Letter to the Editor]. Journal of substance use and addiction treatment. 2024 May 2; 209361.
  65. Irani E, Macleod C, Slat S, Kehne A, Madden E, Jaffe K, Bohnert A, Lagisetty P. The effect of a pilot brief educational intervention on preferences regarding treatments for opioid use disorder. Drug and Alcohol Dependence Reports. 2024 Jun 1; 11:100235.
  66. Talal AH, Markatou M, Liu A, Perumalswami PV, Dinani AM, Tobin JN, Brown LS. Integrated Hepatitis C-Opioid Use Disorder Care Through Facilitated Telemedicine: A Randomized Trial. JAMA. 2024 Apr 23; 331(16):1369-1378.
  67. Lewis KN, Zhang D, Corrales G, Eswaran H, Hayes CJ, Gressler LE. Telehealth Utilization for Opioid Use Disorder: A Nationwide Analysis Before and After the COVID-19 Public Health Emergency Declaration. Telemedicine journal and e-health : the official journal of the American Telemedicine Association. 2024 Apr 15.
  68. Bart G, Korthuis PT, Donohue JM, Hagedorn HJ, Gustafson DH, Bazzi AR, Enns E, McNeely J, Ghitza UE, Magane KM, Baukol P, Vena A, Harris J, Voronca D, Saitz R. Exemplar Hospital initiation trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098B a randomized implementation study to support hospitals in caring for patients with opioid use disorder. Addiction science & clinical practice. 2024 Apr 11; 19(1):29.
  69. Hadlandsmyth K, Lund BC, Gao Y, Strayer AL, Davila H, Hausmann LRM, Schmidt S, Shireman PK, Jacobs MA, Mader MJ, Tessler RA, Duncan CA, Hall DE, Sarrazin MV. Social Determinants of Long-Term Opioid Use Following Total Knee Arthroplasty. The Journal of Knee Surgery. 2024 Aug 1; 37(10):742-748.
  70. Bergman AA, Oberman RS, Taylor SL, Kranke B, Chang ET. Prescribing and Acceptance of Medications for Opioid Use Disorder in VA Primary Care: Veteran and Provider Perspectives. Journal of general internal medicine. 2024 Apr 8.
  71. Krause JS, Dismuke-Greer CE, DiPiro ND, Clark JMR, Laursen-Roesler J. Relationships of Self-reported Opioid Use and Misuse and Pain Severity With Probable Major Depression Among Participants With Spinal Cord Injury. Archives of physical medicine and rehabilitation. 2024 Aug 1; 105(8):1506-1512.
  72. MacLean RR, Ankawi B, Driscoll MA, Gordon MA, Frankforter TL, Nich C, Szollosy SK, Loya JM, Brito L, Ribeiro MIP, Edmond SN, Becker WC, Martino S, Sofuoglu M, Heapy AA. Efficacy of Integrating the Management of Pain and Addiction via Collaborative Treatment (IMPACT) in Individuals With Chronic Pain and Opioid Use Disorder: Protocol for a Randomized Clinical Trial of a Digital Cognitive Behavioral Treatment. JMIR research protocols. 2024 Mar 20; 13:e54342.
  73. Wyse JJ, Eckhardt A, Waller D, Gordon AJ, Shull S, Lovejoy TI, Mackey K, Morasco BJ. Patients' Perspectives on Discontinuing Buprenorphine for the Treatment of Opioid Use Disorder. Journal of addiction medicine. 2024 May 1; 18(3):300-305.
  74. Chung DH, Slat S, Rao A, Thomas J, Kehne A, Macleod C, Madden EF, Lagisetty P. Improving Medical Student Knowledge and Reducing Stigmatizing Attitudes Toward Treating Patients With Opioid Use Disorder. Substance use : research and treatment. 2024 Feb 29; 18:11782218241234808.
  75. Krause JS, DiPiro ND, Dismuke-Greer CE. Self-Reported Prescription Opioid Use Among Participants with Chronic Spinal Cord Injury. Topics in spinal cord injury rehabilitation. 2024 Feb 29; 30(1):131-139.
  76. Mudumbai SC, He H, Chen JQ, Kapoor A, Regala S, Mariano ER, Stafford RS, Abnet CC, Pfeiffer RM, Freedman ND, Etemadi A. Opioid use in cancer patients compared with noncancer pain patients in a veteran population. JNCI cancer spectrum. 2024 Feb 29; 8(2).
  77. Hawkins EJ, Malte CA, Hagedorn HJ, Gordon AJ, Williams EC, Trim RS, Blanchard BE, Lott A, Danner AN, Saxon AJ. Buprenorphine Receipt and Retention for Opioid Use Disorder Following an Initiative to Increase Access in Primary Care. Journal of addiction medicine. 2024 May 1; 18(3):240-247.
  78. Takada S, Seamans MJ, Javanbakht M, Bone C, Ijadi-Maghsoodi R, Shoptaw S, Gelberg L. Nativity and the risk of opioid use disorder among Hispanic/Latinx women in primary care in Los Angeles, CA. Journal of ethnicity in substance abuse. 2024 Feb 7; 1-15.
  79. Billig JI, Bicket MC, Yazdanfar M, Gunaseelan V, Sears ED, Brummett CM, Waljee JF. Cohort study of new off-label gabapentin prescribing in chronic opioid users. Regional Anesthesia and Pain Medicine. 2024 Feb 5; 49(2):88-93.
  80. Qian G, Humphreys K, Goldhaber-Fiebert JD, Brandeau ML. Estimated effectiveness and cost-effectiveness of opioid use disorder treatment under proposed U.S. regulatory relaxations: A model-based analysis. Drug and Alcohol Dependence. 2024 Mar 1; 256:111112.
  81. Hurlocker MC, Kirouac M, Gillezeau C, Hijaz D, Moniz-Lewis DIK, Carlon HA, Coleman GC, Ilgen MA, Pearson MR, Vowles KE, Witkiewitz K. Study Protocol for the Healing Opioid Misuse and Pain Through Engagement Trial: Integrated Treatment for Individuals With Co-occurring Chronic Pain and Opioid Use Disorder. Substance use & addiction journal. 2025 Jan 1; 46(1):192-196, DOI: 10.1177/29767342241228126.
  82. Resnick A, Bergman AA, Oberman RS, Taylor SL, Chuang E, Cummings KM, Chang ET. Knowledge and Attitudes Towards Use of Complementary and Integrative Health Therapies for Veterans with Opioid Use Disorder in the Veterans Health Administration. OBM Integrative and Complementary Medicine. 2024 Jan 31; 9(1):doi:10.21926/obm.icm.2401012.
  83. Lopez I, Fouladvand S, Kollins S, Chen CA, Bertz J, Hernandez-Boussard T, Lembke A, Humphreys K, Miner AS, Chen JH. Predicting premature discontinuation of medication for opioid use disorder from electronic medical records. AMIA ... Annual Symposium proceedings. AMIA Symposium. 2024 Jan 11; 2023:1067-1076.
  84. Watson DP, Tillson M, Taylor L, Xu H, Ouyang F, Beaudoin FL, O'Donnell D, McGuire AB. Results From the POINT Pragmatic Randomized Trial: An Emergency Department-Based Peer Support Specialist Intervention to Increase Opioid Use Disorder Treatment Linkage and Reduce Recurrent Overdose. Substance use & addiction journal. 2024 Jul 1; 45(3):378-389.
  85. Gibbons JB, McCullough JS, Zivin K, Brown ZY, Norton EC. Racial and ethnic disparities in medication for opioid use disorder access, use, and treatment outcomes in Medicare. Journal of substance use and addiction treatment. 2024 Feb 1; 157:209271.
  86. Dember LM, Hsu JY, Bernardo L, Cavanaugh KL, Charytan DM, Crowley ST, Cukor D, Doorenbos AZ, Edwards DA, Esserman D, Fischer MJ, Jhamb M, Joffe S, Johansen KL, Kalim S, Keefe FJ, Kimmel PL, Krebs EE, Kuzla N, Mehrotra R, Mishra P, Pellegrino B, Steel JL, Unruh ML, White DM, Yabes JG, Becker WC, HOPE Consortium. The design and baseline characteristics for the HOPE Consortium Trial to reduce pain and opioid use in hemodialysis. Contemporary clinical trials. 2024 Jan 1; 136:107409.
  87. Liebschutz JM, Subramaniam GA, Stone R, Appleton N, Gelberg L, Lovejoy TI, Bunting AM, Cleland CM, Lasser KE, Beers D, Abrams C, McCormack J, Potter GE, Case A, Revoredo L, Jelstrom EM, Kline MM, Wu LT, McNeely J. Subthreshold opioid use disorder prevention (STOP) trial: a cluster randomized clinical trial: study design and methods. Addiction science & clinical practice. 2023 Nov 18; 18(1):70.
  88. Livingston NA, Sarpong A, Sistad R, Roth C, Banducci AN, Simpson T, Hyde J, Davenport M, Weisberg R. Gender differences in receipt of telehealth versus in person behavioral therapy, medication for opioid use disorder (MOUD), and 90-day MOUD retention during the pandemic: A retrospective veteran cohort study. Journal of substance use and addiction treatment. 2024 Jan 1; 156:209188.
  89. Carr MM, Wolkowicz NR, Cave S, Martino S, Masheb R, Midboe AM. Weight change in a national cohort of U.S. Military Veterans engaged in medication treatment for opioid use disorder. Journal of psychiatric research. 2023 Dec 1; 168:204-212.
  90. Christine PJ, Larochelle MR, Lin LA, McBride J, Tipirneni R. Removal of Medicaid Prior Authorization Requirements and Buprenorphine Treatment for Opioid Use Disorder. JAMA health forum. 2023 Oct 6; 4(10):e233549.
  91. Fortney JC, Ratzliff AD, Blanchard BE, Johnson M, Ferro L, Austin EJ, Williams EC, Duncan MH, Merrill JO, Thomas J, Kitay B, Schoenbaum M, Heagerty PJ, Saxon AJ. Does Screening for Opioid Use Disorder in Primary Care Increase the Percentage of Patients With a New Diagnosis? Annals of internal medicine. 2023 Oct 1; 176(10):1431-1433.
  92. Drexler K, Edens EL, Trafton JA, Compton WM. In the balance: No new diagnosis needed in addition to opioid use disorder to study harms associated with long-term opioid therapy. Addiction (Abingdon, England). 2024 Jan 1; 119(1):6-8.
  93. Frost MC, Malte CA, Hawkins EJ, Glass JE, Hallgren KA, Williams EC. Impact of an intervention to implement provision of opioid use disorder medication among patients with and without co-occurring substance use disorders. Journal of substance use and addiction treatment. 2023 Sep 24; 209175.
  94. Miller WA, Gordon AJ, Clothier BA, Ackland PE, Bounthavong M, Garcia C, Kenny ME, Noorbaloochi S, Hagedorn HJ. Co-occurring implementation strategies: The effects of academic detailing for opioid use disorder campaign on the advancing pharmacological treatments for opioid use disorder (ADaPT-OUD) study. Implementation research and practice. 2023 Sep 14; 4:26334895231199463.
  95. Austin EJ, O'Brien QE, Ruiz MS, Ratzliff AD, Williams EC, Koch U. Patient and Provider Perspectives on Processes of Engagement in Outpatient Treatment for Opioid Use Disorder: A Scoping Review. Community mental health journal. 2023 Sep 5.
  96. Garcia CC, Bounthavong M, Gordon AJ, Gustavson AM, Kenny ME, Miller W, Esmaeili A, Ackland PE, Clothier BA, Bangerter A, Noorbaloochi S, Harris AHS, Hagedorn HJ. Costs of implementing a multi-site facilitation intervention to increase access to medication treatment for opioid use disorder. Implementation science communications. 2023 Aug 10; 4(1):91.
  97. Bridges NC, Taber R, Foulds AL, Bear TM, Cloutier RM, McDonough BL, Gordon AJ, Cochran GT, Donohue JM, Adair D, DiDomenico E, Pringle JL, Gellad WF, Kelley D, Cole ES. Medications for opioid use disorder in rural primary care practices: Patient and provider experiences. Journal of substance use and addiction treatment. 2023 Nov 1; 154:209133.
  98. Austin EJ, Chen J, Briggs ES, Ferro L, Barry P, Heald A, Merrill JO, Curran GM, Saxon AJ, Fortney JC, Ratzliff AD, Williams EC. Integrating Opioid Use Disorder Treatment Into Primary Care Settings. JAMA Network Open. 2023 Aug 1; 6(8):e2328627.
  99. Roberts E, Humphreys K. Does the advent of depot therapy represent a step change in our understanding of opioid use disorder and its treatment? Drug and Alcohol Review. 2024 Jan 1; 43(1):261-264.
  100. Joyce VR, Oliva EM, Garcia CC, Trafton J, Asch SM, Wagner TH, Humphreys K, Owens DK, Bounthavong M. Healthcare costs and use before and after opioid overdose in Veterans Health Administration patients with opioid use disorder. Addiction (Abingdon, England). 2023 Nov 1; 118(11):2203-2214.
  101. Nugent SM, Slatore CG, Winchell K, Handley R, Clayburgh D, Chandra R, Hooker ER, Knight SJ, Morasco BJ. Prevalence and correlates of high-dose opioid use among survivors of head and neck cancer. Head & neck. 2023 Aug 1; 45(8):2058-2067.
  102. Austin AE, Tang L, Kim JY, Allen L, Barnes AJ, Chang CH, Clark S, Cole ES, Durrance CP, Donohue JM, Gordon AJ, Huskamp HA, McDuffie MJ, Mehrotra A, Mohamoud S, Talbert J, Ahrens KA, Applegate M, Hammerslag LR, Lanier P, Tossone K, Zivin K, Burns ME. Trends in Use of Medication to Treat Opioid Use Disorder During the COVID-19 Pandemic in 10 State Medicaid Programs. JAMA health forum. 2023 Jun 2; 4(6):e231422.
  103. French R, Worley J, Lowenstein M, Bogner HR, Calderbank T, DePhilippis D, Forrest A, Connolly Gibbons MB, Harris RA, Heywood S, Kampman K, Mandell DS, McKay JR, Newman ST, Oslin DW, Wadden S, Wolk CB. Adapting psychotherapy in collaborative care for treating opioid use disorder and co-occurring psychiatric conditions in primary care. Families, systems & health : the journal of collaborative family healthcare. 2023 Sep 1; 41(3):377-388.
  104. Ahrens K, Sharbaugh M, Jarlenski MP, Tang L, Allen L, Austin AE, Barnes AJ, Burns ME, Clark S, Zivin K, Mack A, Liu G, Mohamoud S, McDuffie MJ, Hammerslag L, Gordon AJ, Donohue JM, Writing Committee for Medicaid Outcomes Distributed Research Network. Prevalence of Testing for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Among Medicaid Enrollees Treated With Medications for Opioid Use Disorder in 11 States, 2016-2019. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2023 May 24; 76(10):1793-1801.
  105. Carr MM, Lou R, Macdonald-Gagnon G, Peltier MR, Funaro MC, Martino S, Masheb RM. Weight change among patients engaged in medication treatment for opioid use disorder: a scoping review. The American journal of drug and alcohol abuse. 2023 May 18; 1-15.
  106. Frost MC, Soyer EM, Achtmeyer CE, Hawkins EJ, Glass JE, Hallgren KA, Williams EC. Treating opioid use disorder in veterans with co-occurring substance use: a qualitative study with buprenorphine providers in primary care, mental health, and pain settings. Addiction science & clinical practice. 2023 May 4; 18(1):26.
  107. Gordon AJ, Saxon AJ, Kertesz S, Wyse JJ, Manhapra A, Lin LA, Chen W, Hansen J, Pinnell D, Huynh T, Baylis JD, Cunningham FE, Ghitza UE, Bart G, Yu H, Sauer BC. Buprenorphine use and courses of care for opioid use disorder treatment within the Veterans Health Administration. Drug and Alcohol Dependence. 2023 Jul 1; 248:109902.
  108. Frost MC, Hawkins EJ, Glass JE, Hallgren KA, Williams EC. Associations Between Distinct Co-occurring Substance Use Disorders and Receipt of Medications for Opioid Use Disorder in the Veterans Health Administration. Journal of addiction medicine. 2023 May 1; 17(3):278-285.
  109. Turner AP, Arewasikporn A, Hawkins EJ, Suri P, Burns SP, Leipertz SL, Haselkorn JK. Risk Factors for Chronic Prescription Opioid Use in Multiple Sclerosis. Archives of physical medicine and rehabilitation. 2023 May 1.
  110. Thakrar AP, Pytell JD, Stoller KB, Walters V, Weiss RD, Chander G. Transitioning off methadone: A qualitative study exploring why patients discontinue methadone treatment for opioid use disorder. Journal of substance use and addiction treatment. 2023 Jul 1; 150:209055.
  111. Ackland PE, Kenny ME, Clothier BA, Salameh HA, Boening N, Gordon AJ, Noorbaloochi S, Gustavson AM, Miller W, Hagedorn HJ. What Contributes to Sustainability? Examining Access to Medications for Opioid Use Disorder in Low-Adopting VHA Facilities. Journal of general internal medicine. 2023 Sep 1; 38(12):2647-2654.
  112. Goulet J, Cheng Y, Becker W, Brandt C, Sandbrink F, Workman TE, Ma P, Libin A, Shara N, Spevak C, Kupersmith J, Zeng-Treitler Q. Opioid use and opioid use disorder in mono and dual-system users of veteran affairs medical centers. Frontiers in public health. 2023 Apr 4; 11:1148189.
  113. Thompson RG, Bollinger M, Mancino MJ, Hasin D, Han X, Bush KA, Kilts CD, James GA. Smartphone intervention to optimize medication-assisted treatment outcomes for opioid use disorder: study protocol for a randomized controlled trial. Trials. 2023 Apr 4; 24(1):255.
  114. Bounthavong M. Is Providing Medications for Opioid Use Disorder to Incarcerated Individuals a Cost-effective Strategy? JAMA Network Open. 2023 Apr 3; 6(4):e237001.
  115. Nguemeni Tiako MJ, Shofer F, Dolan A, Goldberg EB, Rhodes KV, Hess EP, Bellamkonda VR, Perrone J, Cannuscio CC, Becker L, Rodgers MA, Zyla MM, Bell JJ, McCollum S, Engel-Rebitzer E, Schapira MM, Meisel ZF. Personalized risk communication and opioid prescribing in association with nonprescribed opioid use: A secondary analysis of a randomized controlled trial. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine. 2023 Aug 1; 30(8):851-858.
  116. MacLean RR, Heapy AA, Waters AJ, Wolkowicz N, Szollosy SK, Meyerovich J, Sofuoglu M. Integrating cognitive bias modification for pain and opioid cues into medication for opioid use disorder clinical care: Feasibility, acceptability, and preliminary results. Drug and Alcohol Dependence. 2023 May 1; 246:109857.
  117. Nichols MA, Riley EG, Chao AS, Sales CG, Miller ML, Curran GM, Ott CA, Snyder ME, Hudmon KS. Opioid Use Disorder Curricular Content in US-Based Doctor of Pharmacy Programs. American Journal of Pharmaceutical Education. 2023 Jun 1; 87(6):100061.
  118. Sasson C, Dieujuste N, Klocko R, Basrai Z, Celedon M, Hsiao J, Himstreet J, Hoffman J, Pfaff C, Malmstrom R, Smith J, Holstein A, Johnson-Koenke R. Barriers and facilitators to implementing medications for opioid use disorder and naloxone distribution in Veterans Affairs emergency departments. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine. 2023 Apr 1; 30(4):289-298.
  119. Lott AM, Danner AN, Malte CA, Williams EC, Gordon AJ, Halvorson MA, Saxon AJ, Hagedorn HJ, Sayre GG, Hawkins EJ. Clinician Perspectives on Delivering Medication Treatment for Opioid Use Disorder during the COVID-19 Pandemic: A Qualitative Evaluation. Journal of addiction medicine. 2023 Jul 1; 17(4):e262-e268.
  120. Riggs KR, Cherrington AL, Kertesz SG, Richman JS, DeRussy AJ, Varley AL, Becker WC, Morris MS, Singh JA, Markland AD, Goodin BR. Higher Pain Catastrophizing and Preoperative Pain is Associated with Increased Risk for Prolonged Postoperative Opioid Use. Pain physician. 2023 Mar 1; 26(2):E73-E82.
  121. DeBar LL, Bushey MA, Kroenke K, Bobb JF, Schoenbaum M, Thompson EE, Justice M, Zatzick D, Hamilton LK, McMullen CK, Hallgren KA, Benes LL, Forman DP, Caldeiro RM, Brown RP, Campbell NL, Anderson ML, Son S, Haggstrom DA, Whiteside L, Schleyer TKL, Bradley KA. A patient-centered nurse-supported primary care-based collaborative care program to treat opioid use disorder and depression: Design and protocol for the MI-CARE randomized controlled trial. Contemporary clinical trials. 2023 Apr 1; 127:107124.
  122. Watson DP, Phalen P, Medcalf S, Messmer S, McGuire A. Evaluation of post-discharge engagement for emergency department patients with opioid use history who received telehealth recovery coaching services. Substance abuse treatment, prevention, and policy. 2023 Feb 11; 18(1):9.
  123. Bray BC, Watson DP, Salisbury-Afshar E, Taylor L, McGuire A. Patterns of opioid use behaviors among patients seen in the emergency department: Latent class analysis of baseline data from the POINT pragmatic trial. Journal of substance use and addiction treatment. 2023 Mar 1; 146:208979.
  124. Wyse JJ, Shull S, Lindner S, Morasco BJ, Gordon AJ, Carlson KF, Korthuis PT, Ono SS, Liberto JG, Lovejoy TI. Access to Medications for Opioid Use Disorder in Rural Versus Urban Veterans Health Administration Facilities. Journal of general internal medicine. 2023 Jun 1; 38(8):1871-1876.
  125. Auty SG, Barr KD, Frakt AB, Garrido MM, Strombotne KL. Effect of a Veterans Health Administration mandate to case review patients with opioid prescriptions on mortality among patients with opioid use disorder: a secondary analysis of the STORM randomized control trial. Addiction (Abingdon, England). 2023 May 1; 118(5):870-879.
  126. Conrad M, Steffensmeier KS, Van Tiem J, Obrecht A, Mares J, Mosher HJ, Weg MWV, Sibenaller Z, Stout L, Patel P, Hadlandsmyth K. Military Veterans' Perspectives on Postoperative Opioid Use: A Secondary Analysis of Qualitative Data. Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses. 2023 Jun 1; 38(3):483-487.
  127. Qian G, Rao I, Humphreys K, Owens DK, Brandeau ML. Cost-effectiveness of office-based buprenorphine treatment for opioid use disorder. Drug and Alcohol Dependence. 2023 Feb 1; 243:109762.
  128. Baxley C, Borsari B, Reavis JV, Manuel JK, Herbst E, Becker W, Pennington D, Batki SL, Seal K. Effects of buprenorphine on opioid craving in comparison to other medications for opioid use disorder: A systematic review of randomized controlled trials. Addictive Behaviors. 2023 Apr 1; 139:107589.
  129. Kelley AT, Wilcox J, Baylis JD, Crossnohere NL, Magel J, Jones AL, Gordon AJ, Bridges JFP. Increasing Access to Buprenorphine for Opioid Use Disorder in Primary Care: an Assessment of Provider Incentives. Journal of general internal medicine. 2023 Jul 1; 38(9):2147-2155.
  130. Gibbons JB, McCullough JS, Zivin K, Brown ZY, Norton EC. Association Between Buprenorphine Treatment Gaps, Opioid Overdose, and Health Care Spending in US Medicare Beneficiaries With Opioid Use Disorder. JAMA psychiatry. 2022 Dec 1; 79(12):1173-1179.
  131. Kelley AT, Incze MA, Baylis JD, Calder SG, Weiner SJ, Zickmund SL, Jones AL, Vanneman ME, Conroy MB, Gordon AJ, Bridges JFP. Patient-centered quality measurement for opioid use disorder: Development of a taxonomy to address gaps in research and practice. Substance Abuse. 2022 Dec 1; 43(1):1286-1299.
  132. Sheehan JL, Jacob J, Berinstein EM, Greene-Higgs L, Steiner CA, Berry SK, Shannon C, Cohen-Mekelburg SA, Higgins PDR, Berinstein JA. The Relationship Between Opioid Use and Healthcare Utilization in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Inflammatory Bowel Diseases. 2022 Dec 1; 28(12):1904-1914.
  133. Livingston NA, Davenport M, Head M, Henke R, LeBeau LS, Gibson TB, Banducci AN, Sarpong A, Jayanthi S, Roth C, Camacho-Cook J, Meng F, Hyde J, Mulvaney-Day N, White M, Chen DC, Stein MD, Weisberg R. The impact of COVID-19 and rapid policy exemptions expanding on access to medication for opioid use disorder (MOUD): A nationwide Veterans Health Administration cohort study. Drug and Alcohol Dependence. 2022 Dec 1; 241:109678.
  134. Medicaid Outcomes Distributed Research Network (MODRN), Cole ES, Allen L, Austin A, Barnes A, Chang CH, Clark S, Crane D, Cunningham P, Fry CE, Gordon AJ, Hammerslag L, Idala D, Kennedy S, Kim JY, Krishnan S, Lanier P, Mahakalanda S, Mauk R, McDuffie MJ, Mohamoud S, Talbert J, Tang L, Zivin K, Donohue JM. Outpatient follow-up and use of medications for opioid use disorder after residential treatment among Medicaid enrollees in 10 states. Drug and Alcohol Dependence. 2022 Dec 1; 241:109670.
  135. Hsiao JJ, Celedon MA, Basrai ZI, Sasson C, Cordasco KM. Medications for Opioid Use Disorder Program in a VA Emergency Department. MDEdge: Federal Practioner [Internet]. 2022 Oct 20:(MDedge):258618. Available from: https://www.mdedge.com/fedprac/article/258618/addiction-medicine/medications-opioid-use-disorder-program-va-emergency.
  136. Moyo P, Eliot M, Shah A, Goodyear K, Jutkowitz E, Thomas K, Zullo AR. Discharge locations after hospitalizations involving opioid use disorder among medicare beneficiaries. Addiction science & clinical practice. 2022 Oct 8; 17(1):57.
  137. Frost MC, Zhang L, Kim HM, Lin LA. Use of and Retention on Video, Telephone, and In-Person Buprenorphine Treatment for Opioid Use Disorder During the COVID-19 Pandemic. JAMA Network Open. 2022 Oct 3; 5(10):e2236298.
  138. Kember RL, Vickers-Smith R, Xu H, Toikumo S, Niarchou M, Zhou H, Hartwell EE, Crist RC, Rentsch CT, Million Veteran Program, Davis LK, Justice AC, Sanchez-Roige S, Kampman KM, Gelernter J, Kranzler HR. Cross-ancestry meta-analysis of opioid use disorder uncovers novel loci with predominant effects in brain regions associated with addiction. Nature neuroscience. 2022 Oct 1; 25(10):1279-1287.
  139. Johnson DG, Ho VT, Hah JM, Humphreys K, Carroll I, Curtin C, Asch SM, Hernandez-Boussard T. Prescription quantity and duration predict progression from acute to chronic opioid use in opioid-naïve Medicaid patients. PLOS digital health. 2022 Aug 25; 1(8).
  140. Zeliadt SB, Douglas JH, Gelman H, Coggeshall S, Taylor SL, Kligler B, Bokhour BG. Effectiveness of a whole health model of care emphasizing complementary and integrative health on reducing opioid use among patients with chronic pain. BMC health services research. 2022 Aug 17; 22(1):1053.
  141. Epperson MV, VanHorn A, Kim HM, Kim JC, Zopf D. Pain management after microtia repair with costal cartilage: De-escalation and opioid use reduction. International journal of pediatric otorhinolaryngology. 2022 Oct 1; 161:111270.
  142. Mosher H. Treating hospitalized people who have opioid use disorder: Coming to consensus. Journal of hospital medicine. 2022 Sep 1; 17(9):774-775.
  143. Lin LA, Zhang L, Kim HM, Frost MC. Impact of COVID-19 Telehealth Policy Changes on Buprenorphine Treatment for Opioid Use Disorder. The American journal of psychiatry. 2022 Oct 1; 179(10):740-747.
  144. Deak JD, Zhou H, Galimberti M, Levey DF, Wendt FR, Sanchez-Roige S, Hatoum AS, Johnson EC, Nunez YZ, Demontis D, Børglum AD, Rajagopal VM, Jennings MV, Kember RL, Justice AC, Edenberg HJ, Agrawal A, Polimanti R, Kranzler HR, Gelernter J. Genome-wide association study in individuals of European and African ancestry and multi-trait analysis of opioid use disorder identifies 19 independent genome-wide significant risk loci. Molecular Psychiatry. 2022 Oct 1; 27(10):3970-3979.
  145. Sousa JL, Raja P, Huskamp HA, Mehrotra A, Busch AB, Barnett ML, Uscher-Pines L. Perspectives of Patients Receiving Telemedicine Services for Opioid Use Disorder Treatment: A Qualitative Analysis of User Experiences. Journal of addiction medicine. 2022 Nov 1; 16(6):702-708.
  146. Fernandez AC, Bohnert A, Gunaseelan V, Motamed M, Waljee JF, Brummett CM. Identifying Persistent Opioid Use After Surgery: The Reliability of Pharmacy Dispensation Databases. Annals of surgery. 2023 Jul 1; 278(1):e20-e26.
  147. Powell VD, Macleod C, Sussman J, Lin LA, Bohnert ASB, Lagisetty P. Variation in Clinical Characteristics and Longitudinal Outcomes in Individuals with Opioid Use Disorder Diagnosis Codes. Journal of general internal medicine. 2023 Feb 1; 38(3):699-706.
  148. Stringfellow EJ, Lim TY, Humphreys K, DiGennaro C, Stafford C, Beaulieu E, Homer J, Wakeland W, Bearnot B, McHugh RK, Kelly J, Glos L, Eggers SL, Kazemi R, Jalali MS. Reducing opioid use disorder and overdose deaths in the United States: A dynamic modeling analysis. Science advances. 2022 Jun 24; 8(25):eabm8147.
  149. Wyse JJ, Mackey K, Lovejoy TI, Kansagara D, Tuepker A, Gordon AJ, Todd Korthuis P, Herreid-O'Neill A, Williams B, Morasco BJ. Expanding access to medications for opioid use disorder through locally-initiated implementation. Addiction science & clinical practice. 2022 Jun 20; 17(1):32.
  150. Lin LA, Powell VD, Macleod C, Bohnert ASB, Lagisetty P. Factors associated with clinician treatment recommendations for patients with a new diagnosis of opioid use disorder. Journal of substance abuse treatment. 2022 Oct 1; 141:108827.
  151. Holeman TA, Buys MJ, Bayless K, Anderson Z, Hales J, Brooke BS. Complete opioid cessation after surgery improves patient-reported pain measures among chronic opioid users. Surgery. 2022 Sep 1; 172(3):943-948.
  152. Frost MC, Richards JE, Blosnich JR, Hawkins EJ, Tsui JI, Edelman EJ, Williams EC. Association between clinically recognized suicidality and subsequent initiation or continuation of medications for opioid use disorder. Drug and Alcohol Dependence. 2022 Aug 1; 237:109521.
  153. Hadlandsmyth K, Burgess DJ, Leparski RF, Odom AS, Campbell EJ, Obrecht AA, Adamowicz JL, Cho H, Steffensmeier KS, Johnson NL, Richards CC, Vander Weg MW, Lund BC, Yoon P, Mosher HJ. The Perioperative Pain Self-Management (PePS) randomized controlled trial protocol: Preventing chronic post-surgical pain and prolonged opioid use. Contemporary clinical trials. 2022 Jul 1; 118:106810.
  154. Austin EJ, Briggs ES, Ferro L, Barry P, Heald A, Curran GM, Saxon AJ, Fortney J, Ratzliff AD, Williams EC. Integrating Routine Screening for Opioid Use Disorder into Primary Care Settings: Experiences from a National Cohort of Clinics. Journal of general internal medicine. 2023 Feb 1; 38(2):332-340.
  155. Love T, Shabalin AA, Kember RL, Docherty AR, Zhou H, Koppelmans V, Gelernter J, Baker AK, Hartwell E, Dubroff J, Zubieta JK, Kranzler HR. Unique and joint associations of polygenic risk for major depression and opioid use disorder with endogenous opioid system function. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2022 Sep 1; 47(10):1784-1790.
  156. Zaller N, Gardner A, Borders T, Drummond KL. A Qualitative Exploration of Primary Care Practitioner Views About Training to Treat Opioid Use Disorder. SSRN Electronic Journal. 2022 Apr 15; http://dx.doi.org/10.2139/ssrn.4078644.
  157. Radmall AO, Calder S, Codell N, Kelley AT, Hawkins E, Jones AL, Hagedorn HJ, Reynolds MA, Gordon AJ. Roles and Perceptions of Nurses During Implementation of a Medication Treatment for Opioid Use Disorder National Initiative. Journal of addictions nursing. 2022 Apr 1; 33(2):70-79.
  158. Bergen AW, Baurley JW, Ervin CM, McMahan CS, Bible J, Stafford RS, Mudumbai SC, Saxon AJ. Effects of Buprenorphine Dose and Therapeutic Engagement on Illicit Opiate Use in Opioid Use Disorder Treatment Trials. International journal of environmental research and public health. 2022 Mar 30; 19(7).
  159. Pickard JG, van den Berk-Clark C, Matthieu MM. Association of Medication-Assisted Treatment and Age With Treatment Completion Among Veterans Seeking Non-VA Treatment for Opioid use Disorder at Non-Veterans Health Administration Facilities. Military medicine. 2022 Mar 28; 187(3-4):504-512.
  160. Chanfreau-Coffinier C, Tuteja S, Hull LE, MacDonald S, Efimova O, Bates J, Voora D, Oslin DW, DuVall SL, Lynch JA. Drug-drug-gene interaction risk among opioid users in the U.S. Department of Veterans Affairs. Pain. 2022 Dec 1; 163(12):2390-2397.
  161. Beckman KL, Williams EC, Hebert P, Hawkins EJ, Littman AJ, Lehavot K. The impact of military sexual trauma and gender on receipt of evidence-based medication treatment among veterans with opioid use disorder. Journal of substance abuse treatment. 2022 Aug 1; 139:108775.
  162. Oldfield BJ, Li Y, Vickers-Smith R, Barry DT, Crystal S, Gordon KS, Kerns RD, Williams EC, Marshall BDL, Edelman EJ. Longitudinal analysis of the prevalence and correlates of heavy episodic drinking and self-reported opioid use among a national cohort of patients with HIV. Alcoholism, clinical and experimental research. 2022 Apr 1; 46(4):600-613.
  163. Cochran G, Cole ES, Sharbaugh M, Nagy D, Gordon AJ, Gellad WF, Pringle J, Bear T, Warwick J, Drake C, Chang CH, DiDomenico E, Kelley D, Donohue J. Provider and Patient-panel Characteristics Associated With Initial Adoption and Sustained Prescribing of Medication for Opioid Use Disorder. Journal of addiction medicine. 2022 Mar 1; 16(2):e87-e96.
  164. Thakrar AP. Short-Acting Opioids for Hospitalized Patients With Opioid Use Disorder. JAMA internal medicine. 2022 Mar 1; 182(3):247-248.
  165. Ameral V, Hocking E, Leviyah X, Newberger NG, Timko C, Livingston N. Innovating for real-world care: A systematic review of interventions to improve post-detoxification outcomes for opioid use disorder. Drug and Alcohol Dependence. 2022 Apr 1; 233:109379.
  166. Bicket MC, Lin LA, Waljee J. New Persistent Opioid Use After Surgery: A Risk Factor for Opioid Use Disorder? Annals of surgery. 2022 Feb 1; 275(2):e288-e289.
  167. Kramer JR, Puenpatom A, Cao Y, Yu X, El-Serag HB, Kanwal F. Treatment of hepatitis C virus infection in people with opioid use disorder: a real-world study of elbasvir/grazoprevir in a US Department of Veterans Affairs population. The American journal of drug and alcohol abuse. 2022 Jul 4; 48(4):445-453.
  168. Faiz J, Bernstein E, Dugas JN, Schechter-Perkins EM, Nentwich L, Nelson KP, Cleveland Manchanda EC, Young L, Pare JR. Racial equity in linkage to inpatient opioid use disorder treatment in patients that received emergency care. The American journal of emergency medicine. 2022 Apr 1; 54:221-227.
  169. Rubin JB, Lai JC, Leonard S, Seal K, Hoggatt KJ, Keyhani S. Long-Term Opioid Use Among Veterans with Cirrhosis: High-Dose Prescriptions in an Exceedingly High-Risk Population. Journal of general internal medicine. 2022 Sep 1; 37(12):3205-3207.
  170. Incze MA, Kelley AT, Gordon AJ. Champions Among Us: Leading Primary Care to the Forefront of Opioid Use Disorder Treatment. Journal of general internal medicine. 2022 May 1; 37(7):1771-1773.
  171. Sung ML, Black AC, Blevins D, Henry BF, Cates-Wessel K, Dawes MA, Drexler K, Hagle H, Molfenter T, Levin FR, Becker WC, Edelman EJ. Adaptations to Opioid Use Disorder Care During the COVID-19 Pandemic: A National Survey of Prescribers. Journal of addiction medicine. 2022 Sep 1; 16(5):505-513.
  172. Ervin-Sikhondze BA, Moser SE, Pierce J, Dickens JR, Lagisetty PA, Urquhart AG, Hallstrom BR, Brummett CM, McAfee J. Reasons for Preoperative Opioid Use Are Associated with Persistent Use following Surgery Among Patients Undergoing Total Knee and Hip Arthroplasty. Pain medicine (Malden, Mass.). 2022 Jan 3; 23(1):19-28.
  173. Hagedorn HJ, Gustavson AM, Ackland PE, Bangerter A, Bounthavong M, Clothier B, Harris AHS, Kenny ME, Noorbaloochi S, Salameh HA, Gordon AJ. Advancing Pharmacological Treatments for Opioid Use Disorder (ADaPT-OUD): an Implementation Trial in Eight Veterans Health Administration Facilities. Journal of general internal medicine. 2022 Nov 1; 37(14):3594-3602.
  174. Frank CJ, Lin LA. Defining and supporting high-quality telehealth for patients with opioid use disorder: The promise and potential pitfalls of telehealth expansion. Substance Abuse. 2022 Jan 1; 43(1):1370-1373.
  175. Hayes CJ, Cucciare MA, Martin BC, Hudson TJ, Bush K, Lo-Ciganic W, Yu H, Charron E, Gordon AJ. Using data science to improve outcomes for persons with opioid use disorder. Substance Abuse. 2022 Jan 1; 43(1):956-963.
  176. Priest KC, King CA, Englander H, Lovejoy TI, McCarty D. Differences in the delivery of medications for opioid use disorder during hospitalization by racial categories: A retrospective cohort analysis. Substance Abuse. 2022 Jan 1; 43(1):1251-1259.
  177. Bushey MA, Wu J, Outcalt SD, Krebs EE, Ang D, Kline M, Yu Z, Bair MJ. Opioid Use as a Predictor of Pain Outcomes in Iraq and Afghanistan Veterans with Chronic Pain: Analysis of a Randomized Controlled Trial. Pain medicine (Malden, Mass.). 2021 Dec 11; 22(12):2964-2970.
  178. Hagan S, Achtmeyer CE, Hood C, Hawkins EJ, Williams EC. Opioid use disorder from poppy seed tea successfully treated with buprenorphine in primary care: a case report. Addiction science & clinical practice. 2021 Dec 3; 16(1):71.
  179. Hawkins EJ, Malte CA, Gordon AJ, Williams EC, Hagedorn HJ, Drexler K, Blanchard BE, Burden JL, Knoeppel J, Danner AN, Lott A, Liberto JG, Saxon AJ. Accessibility to Medication for Opioid Use Disorder After Interventions to Improve Prescribing Among Nonaddiction Clinics in the US Veterans Health Care System. JAMA Network Open. 2021 Dec 1; 4(12):e2137238.
  180. Beckman KL, Williams EC, Hebert PL, Frost MC, Rubinsky AD, Hawkins EJ, Littman AJ, Lehavot K. Associations Among Military Sexual Trauma, Opioid Use Disorder, and Gender. American journal of preventive medicine. 2022 Mar 1; 62(3):377-386.
  181. Huskamp HA, Riedel L, Uscher-Pines L, Busch AB, Barnett ML, Raja P, Mehrotra A. Initiating Opioid Use Disorder Medication via Telemedicine During COVID-19: Implications for Proposed Reforms to the Ryan Haight Act. Journal of general internal medicine. 2022 Jan 1; 37(1):162-167.
  182. Han BH, Tuazon E, Y Wei M, Paone D. Multimorbidity and Inpatient Utilization Among Older Adults with Opioid Use Disorder in New York City. Journal of general internal medicine. 2022 May 1; 37(7):1634-1640.
  183. Frost MC, Lampert H, Tsui JI, Iles-Shih MD, Williams EC. The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review. Addiction science & clinical practice. 2021 Oct 11; 16(1):62.
  184. Hatoum AS, Wendt FR, Galimberti M, Polimanti R, Neale B, Kranzler HR, Gelernter J, Edenberg HJ, Agrawal A. Ancestry may confound genetic machine learning: Candidate-gene prediction of opioid use disorder as an example. Drug and Alcohol Dependence. 2021 Dec 1; 229(Pt B):109115.
  185. Spelman JF, Edens EL, Maya S, Moore BA, Boggs A, MacLean RR, Ackland P, Becker WC, Lynch D, Garcia-Vassallo M, Burgo AL, Rosen MI, Gordon AJ. A Facility-Wide Plan to Increase Access to Medication for Opioid Use Disorder in Primary Care and General Mental Health Settings. Federal practitioner : for the health care professionals of the VA, DoD, and PHS. 2021 Oct 1; 38(10):460-464.
  186. Taylor EN, Timko C, Binswanger IA, Harris AHS, Stimmel M, Smelson D, Finlay AK. A national survey of barriers and facilitators to medications for opioid use disorder among legal-involved veterans in the Veterans Health Administration. Substance Abuse. 2021 Sep 29; 43(1):556-563.
  187. Ward R, Tang YL, Axon RN, Casarella J, Whitfield N, Rauch SAM. Effectiveness of a substance use treatment program for veterans with chronic pain and opioid use disorder. Journal of substance abuse treatment. 2022 Jan 1; 132:108635.
  188. Kiang MV, Barnett ML, Wakeman SE, Humphreys K, Tsai AC. Robustness of estimated access to opioid use disorder treatment providers in rural vs. urban areas of the United States. Drug and Alcohol Dependence. 2021 Nov 1; 228:109081.
  189. Magel J, Kietrys D, Kruger ES, Fritz JM, Gordon AJ. Physical therapists should play a greater role in managing patients with opioid use and opioid misuse. Substance Abuse. 2021 Sep 15; 42(3):255-260.
  190. Wyse JJ, McGinnis KA, Edelman EJ, Gordon AJ, Manhapra A, Fiellin DA, Moore BA, Korthuis PT, Kennedy AJ, Oldfield BJ, Gaither JR, Gordon KS, Skanderson M, Barry DT, Bryant K, Crystal S, Justice AC, Kraemer KL. Twelve-Month Retention in Opioid Agonist Treatment for Opioid Use Disorder Among Patients With and Without HIV. AIDS and behavior. 2022 Mar 1; 26(3):975-985.
  191. Hawkins EJ, Danner AN, Malte CA, Blanchard BE, Williams EC, Hagedorn HJ, Gordon AJ, Drexler K, Burden JL, Knoeppel J, Lott A, Sayre GG, Midboe AM, Saxon AJ. Clinical leaders and providers' perspectives on delivering medications for the treatment of opioid use disorder in Veteran Affairs' facilities. Addiction science & clinical practice. 2021 Sep 6; 16(1):55.
  192. Kelley AT, Dungan MT, Gordon AJ. Barriers and Facilitators to Buprenorphine Prescribing for Opioid Use Disorder in the Veterans Health Administration During COVID-19. Journal of addiction medicine. 2021 Sep 1; 15(5):439-440.
  193. Baker JF, Stokes A, Pedro S, Mikuls TR, George M, England BR, Sayles H, Wolfe F, Michaud K. Obesity and the Risk of Incident Chronic Opioid Use in Rheumatoid Arthritis. Arthritis care & research. 2021 Oct 1; 73(10):1405-1412.
  194. Riedel L, Uscher-Pines L, Mehrotra A, Busch AB, Barnett ML, Raja P, Huskamp HA. Use of telemedicine for opioid use disorder treatment - Perceptions and experiences of opioid use disorder clinicians. Drug and Alcohol Dependence. 2021 Nov 1; 228:108999.
  195. Chow SL, Sasson C, Benjamin IJ, Califf RM, Compton WM, Oliva EM, Robson C, Sanchez EJ. Opioid Use and Its Relationship to Cardiovascular Disease and Brain Health: A Presidential Advisory From the American Heart Association. Circulation. 2021 Sep 28; 144(13):e218-e232.
  196. Brown-Taylor L, Beckner A, Scaff KE, Fritz JM, Buys MJ, Patel S, Bayless K, Brooke BS. Relationships between physical therapy intervention and opioid use: A scoping review. PM & R : the journal of injury, function, and rehabilitation. 2022 Jul 1; 14(7):837-854.
  197. Blevins D, Henry BF, Sung M, Edelman EJ, Black AC, Dawes M, Molfenter T, Hagle H, Drexler K, Cates-Wessel K, Levin FR. Well-Being of Health Care Professionals Treating Opioid Use Disorder During the COVID-19 Pandemic: Results From a National Survey. Psychiatric services (Washington, D.C.). 2022 Apr 1; 73(4):374-380.
  198. Gustavson AM, Kenny ME, Wisdom JP, Salameh HA, Ackland PE, Gordon AJ, Hagedorn HJ. Fluctuations in barriers to medication treatment for opioid use disorder prescribing over the course of a one-year external facilitation intervention. Addiction science & clinical practice. 2021 Aug 6; 16(1):51.
  199. Medicaid Outcomes Distributed Research Network (MODRN) , Donohue JM, Jarlenski MP, Kim JY, Tang L, Ahrens K, Allen L, Austin A, Barnes AJ, Burns M, Chang CH, Clark S, Cole E, Crane D, Cunningham P, Idala D, Junker S, Lanier P, Mauk R, McDuffie MJ, Mohamoud S, Pauly N, Sheets L, Talbert J, Zivin K, Gordon AJ, Kennedy S. Use of Medications for Treatment of Opioid Use Disorder Among US Medicaid Enrollees in 11 States, 2014-2018. JAMA. 2021 Jul 13; 326(2):154-164.
  200. Fairley M, Humphreys K, Joyce VR, Bounthavong M, Trafton J, Combs A, Oliva EM, Goldhaber-Fiebert JD, Asch SM, Brandeau ML, Owens DK. Cost-effectiveness of Treatments for Opioid Use Disorder. JAMA psychiatry. 2021 Jul 1; 78(7):767-777.
  201. Rogal S, Youk A, Agbalajobi O, Zhang H, Gellad W, Fine MJ, Belperio P, Morgan T, Good CB, Kraemer K. Medication Treatment of Active Opioid Use Disorder in Veterans With Cirrhosis. The American journal of gastroenterology. 2021 Jul 1; 116(7):1406-1413.
  202. Kelley AT, Smid MC, Baylis JD, Charron E, Binns-Calvey AE, Archer S, Weiner SJ, Begaye LJ, Cochran G. Development of an unannounced standardized patient protocol to evaluate opioid use disorder treatment in pregnancy for American Indian and rural communities. Addiction science & clinical practice. 2021 Jun 25; 16(1):40.
  203. Ching JH, Owens DK, Trafton JA, Goldhaber-Fiebert JD, Salomon JA. Impact of treatment duration on mortality among Veterans with opioid use disorder in the United States Veterans Health Administration. Addiction (Abingdon, England). 2021 Dec 1; 116(12):3494-3503.
  204. Kennedy AJ, McGinnis KA, Merlin JS, Edelman EJ, Gordon AJ, Korthuis PT, Skanderson M, Williams EC, Wyse J, Oldfield B, Bryant K, Justice A, Fiellin DA, Kraemer KL. Impact of intensity of behavioral treatment, with or without medication treatment, for opioid use disorder on HIV outcomes in persons with HIV. Journal of substance abuse treatment. 2022 Jan 1; 132:108509.
  205. Lin LA, Fortney JC, Bohnert ASB, Coughlin LN, Zhang L, Piette JD. Comparing telemedicine to in-person buprenorphine treatment in U.S. veterans with opioid use disorder. Journal of substance abuse treatment. 2022 Feb 1; 133:108492.
  206. Vakkalanka P, Lund BC, Arndt S, Field W, Charlton M, Ward MM, Carnahan RM. Association Between Buprenorphine for Opioid Use Disorder and Mortality Risk. American journal of preventive medicine. 2021 Sep 1; 61(3):418-427.
  207. Robles M, Mortazavi L, Vannerson J, Matthias MS. How a Medication for Opioid Use Disorder Curriculum Translates into Experiences and Internal Medicine Residents' Understanding of Patients with Opioid Use Disorder. Teaching and learning in medicine. 2021 May 11; 34(5):514-521.
  208. Chen J, Cabudol M, Williams EC, Merrill JO, Tsui JI, Klein JW. Perspectives on electronic portal use among patients treated with medications for opioid use disorder in primary care. Journal of substance abuse treatment. 2021 Jul 1; 126:108463.
  209. Brown CR, Groeneveld P, Desai N. Persistent Opioid Use May Be a Failure of Pain Management Rather Than Prescribing-Reply. JAMA cardiology. 2021 May 1; 6(5):602-603.
  210. Moore MN, Wallace BI. Glucocorticoid and opioid use in rheumatoid arthritis management. Current opinion in rheumatology. 2021 May 1; 33(3):277-283.
  211. Finlay AK, Harris AHS, Timko C, Yu M, Smelson D, Stimmel M, Binswanger IA. Disparities in Access to Medications for Opioid Use Disorder in the Veterans Health Administration. Journal of addiction medicine. 2021 Apr 1; 15(2):143-149.
  212. Morse E, Binswanger IA, Taylor E, Gray C, Stimmel M, Timko C, Harris AHS, Smelson D, Finlay AK. Strategies to improve implementation of medications for opioid use disorder reported by veterans involved in the legal system: A qualitative study. Journal of substance abuse treatment. 2021 Oct 1; 129:108353.
  213. Sherva R, Zhu C, Wetherill L, Edenberg HJ, Johnson E, Degenhardt L, Agrawal A, Martin NG, Nelson E, Kranzler HR, Gelernter J, Farrer LA. Genome-wide association study of phenotypes measuring progression from first cocaine or opioid use to dependence reveals novel risk genes. Exploration of medicine. 2021 Feb 28; 2:60-73.
  214. Harris RA, Mandell DS, Kampman KM, Bao Y, Campbell K, Cidav Z, Coviello DM, French R, Livesey C, Lowenstein M, Lynch KG, McKay JR, Oslin DW, Wolk CB, Bogner HR. Collaborative care in the treatment of opioid use disorder and mental health conditions in primary care: A clinical study protocol. Contemporary clinical trials. 2021 Apr 1; 103:106325.
  215. Cole ES, Drake C, DiDomenico E, Sharbaugh M, Kim JY, Nagy D, Cochran G, Gordon AJ, Gellad WF, Pringle J, Warwick J, Chang CH, Kmiec J, Kelley D, Donohue JM. Patterns of clinic switching and continuity of medication for opioid use disorder in a Medicaid-enrolled population. Drug and Alcohol Dependence. 2021 Apr 1; 221:108633.
  216. Gustavson AM, Wisdom JP, Kenny ME, Salameh HA, Ackland PE, Clothier B, Noorbaloochi S, Gordon AJ, Hagedorn HJ. Early impacts of a multi-faceted implementation strategy to increase use of medication treatments for opioid use disorder in the Veterans Health Administration. Implementation science communications. 2021 Feb 15; 2(1):20.
  217. Lagisetty P, Garpestad C, Larkin A, Macleod C, Antoku D, Slat S, Thomas J, Powell V, Bohnert ASB, Lin LA. Identifying individuals with opioid use disorder: Validity of International Classification of Diseases diagnostic codes for opioid use, dependence and abuse. Drug and Alcohol Dependence. 2021 Apr 1; 221:108583.
  218. Adams JW, Li Y, Barry DT, Gordon KS, Kerns RD, Oldfield BJ, Rentsch CT, Marshall BDL, Edelman EJ. Long-term Patterns of Self-reported Opioid Use, VACS Index, and Mortality Among People with HIV Engaged in Care. AIDS and behavior. 2021 Sep 1; 25(9):2951-2962.
  219. DeRonne BM, Wong KR, Schultz E, Jones E, Krebs EE. Implementation of a pharmacist care manager model to expand availability of medications for opioid use disorder. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2021 Feb 8; 78(4):354-359.
  220. Incze MA, Kelley AT, Gordon AJ. Improving Opioid Use Disorder Treatment through Quality Assessment. Journal of general internal medicine. 2021 Sep 1; 36(9):2820-2822.
  221. Becker WC, Heimer R, Dormitzer CM, Doernberg M, D'Onofrio G, Grau LE, Hawk K, Lin HJ, Secora AM, Fiellin DA. Merging statewide data in a public/university collaboration to address opioid use disorder and overdose. Addiction science & clinical practice. 2021 Jan 4; 16(1):1.
  222. Balbale SN, Cao L, Trivedi I, Stulberg JJ, Suda KJ, Gellad WF, Evans CT, Lambert BL, Jordan N, Keefer LA. High-Dose Opioid Use Among Veterans with Unexplained Gastrointestinal Symptoms Versus Structural Gastrointestinal Diagnoses. Digestive diseases and sciences. 2021 Nov 1; 66(11):3938-3950.
  223. Cron DC, Tincopa MA, Lee JS, Waljee AK, Hammoud A, Brummett CM, Waljee JF, Englesbe MJ, Sonnenday CJ. Prevalence and Patterns of Opioid Use Before and After Liver Transplantation. Transplantation. 2021 Jan 1; 105(1):100-107.
  224. Khatri UG, Aronowitz SV. Considering the harms of our habits: The reflexive urine drug screen in opioid use disorder treatment. Journal of substance abuse treatment. 2021 Apr 1; 123:108258.
  225. Howell BA, Abel EA, Park D, Edmond SN, Leisch LJ, Becker WC. Validity of Incident Opioid Use Disorder (OUD) Diagnoses in Administrative Data: a Chart Verification Study. Journal of general internal medicine. 2021 May 1; 36(5):1264-1270.
  226. Chang ET, Oberman RS, Cohen AN, Taylor SL, Gumm E, Mardian AS, Toy S, Revote A, Lewkowitz B, Yano EM. Increasing Access to Medications for Opioid Use Disorder and Complementary and Integrative Health Services in Primary Care. Journal of general internal medicine. 2020 Dec 1; 35(Suppl 3):918-926.
  227. Mackey K, Veazie S, Anderson J, Bourne D, Peterson K. Barriers and Facilitators to the Use of Medications for Opioid Use Disorder: a Rapid Review. Journal of general internal medicine. 2020 Dec 1; 35(Suppl 3):954-963.
  228. Priest KC, McCarty D, Lovejoy TI. Expanding Access to Medications for Opioid Use Disorder: Program and Policy Approaches from Outside the Veterans Health Administration. Journal of general internal medicine. 2020 Dec 1; 35(Suppl 3):886-890.
  229. Veazie S, Mackey K, Peterson K, Bourne D. Managing Acute Pain in Patients Taking Medication for Opioid Use Disorder: a Rapid Review. Journal of general internal medicine. 2020 Dec 1; 35(Suppl 3):945-953.
  230. Zhou H, Rentsch CT, Cheng Z, Kember RL, Nunez YZ, Sherva RM, Tate JP, Dao C, Xu K, Polimanti R, Farrer LA, Justice AC, Kranzler HR, Gelernter J, Veterans Affairs Million Veteran Program. Association of OPRM1 Functional Coding Variant With Opioid Use Disorder: A Genome-Wide Association Study. JAMA psychiatry. 2020 Oct 1; 77(10):1072-1080.
  231. Gustavson AM, Gordon AJ, Kenny ME, McHenry H, Gronek J, Ackland PE, Hagedorn HJ. Response to coronavirus 2019 in Veterans Health Administration facilities participating in an implementation initiative to enhance access to medication for opioid use disorder. Substance Abuse. 2020 Sep 16; 41(4):413-418.
  232. Giannitrapani KF, Ackland PE, Holliday J, Zeliadt S, Olson J, Kligler B, Taylor SL. Provider Perspectives of Battlefield Acupuncture: Advantages, Disadvantages and Its Potential Role in Reducing Opioid Use for Pain. Medical care. 2020 Sep 1; 58 Suppl 2 9S:S88-S93.
  233. Wilson AC, Morasco BJ, Holley AL, Feldstein Ewing SW. Patterns of opioid use in adolescents receiving prescriptions: The role of psychological and pain factors. The American Psychologist. 2020 Sep 1; 75(6):748-760.
  234. Uscher-Pines L, Sousa J, Raja P, Mehrotra A, Barnett M, Huskamp HA. Treatment of opioid use disorder during COVID-19: Experiences of clinicians transitioning to telemedicine. Journal of substance abuse treatment. 2020 Nov 1; 118:108124.
  235. Buys MJ, Bayless K, Romesser J, Anderson Z, Patel S, Zhang C, Presson AP, Brooke BS. Opioid use among veterans undergoing major joint surgery managed by a multidisciplinary transitional pain service. Regional Anesthesia and Pain Medicine. 2020 Nov 1; 45(11):847-852.
  236. Bokhour BG, Gelman H, Gaj L, Thomas E, Barker A, Whittington M, Douglas J, DeFaccio R, Taylor S, Zeliadt S. Addressing Consumer and Patients' Preferences and Needs Whole Health System of Care Improves Health and Well-Being and Reduces Opioid Use for Veterans with Chronic Pain. [Abstract]. Health services research. 2020 Aug 20; 55(51):7-8.
  237. Brown CR, Chen Z, Khurshan F, Groeneveld PW, Desai ND. Development of Persistent Opioid Use After Cardiac Surgery. JAMA cardiology. 2020 Aug 1; 5(8):889-896.
  238. Chan B, Freeman M, Ayers C, Korthuis PT, Paynter R, Kondo K, Kansagara D. A systematic review and meta-analysis of medications for stimulant use disorders in patients with co-occurring opioid use disorders. Drug and Alcohol Dependence. 2020 Nov 1; 216:108193.
  239. Kwan SY, Lancaster E, Dixit A, Inglis-Arkell C, Manuel S, Suh I, Shen WT, Seib CD. Reducing Opioid Use in Endocrine Surgery Through Patient Education and Provider Prescribing Patterns. The Journal of surgical research. 2020 Dec 1; 256:303-310.
  240. Lo-Ciganic WH, Huang JL, Zhang HH, Weiss JC, Kwoh CK, Donohue JM, Gordon AJ, Cochran G, Malone DC, Kuza CC, Gellad WF. Using machine learning to predict risk of incident opioid use disorder among fee-for-service Medicare beneficiaries: A prognostic study. PLoS ONE. 2020 Jul 17; 15(7):e0235981.
  241. Bishop MO, Bayman EO, Hadlandsmyth K, Lund BC, Kang S. Opioid use trajectories after thoracic surgery among veterans in the United States. European journal of pain (London, England). 2020 Sep 1; 24(8):1569-1584.
  242. Lin LA, Bohnert ASB, Blow FC, Gordon AJ, Ignacio RV, Kim HM, Ilgen MA. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration. Addiction (Abingdon, England). 2021 Jan 1; 116(1):96-104.
  243. Hser YI, Mooney LJ. Integrating Telemedicine for Medication Treatment for Opioid Use Disorder in Rural Primary Care: Beyond the COVID Pandemic. The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association. 2021 Jan 1; 37(1):246-248.
  244. Khatri UG, Perrone J. Opioid Use Disorder and COVID-19: Crashing of the Crises. Journal of addiction medicine. 2020 Jul 1; 14(4):e6-e7.
  245. Shover CL, Vest NA, Chen D, Stueber A, Falasinnu TO, Hah JM, Kim J, Mackey I, Weber KA, Ziadni M, Humphreys K. Association of State Policies Allowing Medical Cannabis for Opioid Use Disorder With Dispensary Marketing for This Indication. JAMA Network Open. 2020 Jul 1; 3(7):e2010001.
  246. Finlay AK, Morse E, Stimmel M, Taylor E, Timko C, Harris AHS, Smelson D, Yu M, Blue-Howells J, Binswanger IA. Barriers to Medications for Opioid Use Disorder Among Veterans Involved in the Legal System: a Qualitative Study. Journal of general internal medicine. 2020 Sep 1; 35(9):2529-2536.
  247. Caulkins JP, Humphreys KN. Preventing opioid use and addiction: New thinking and the latest evidence. The Opioid Crisis In America: A paper series from the Foreign Policy and Global Economy & Development programs at Brookings [Internet]. 2020 Jun 22: Available from: Washington, DC.
  248. Dora-Laskey AD, Goldstick JE, Arterberry BJ, Roberts SJ, Haffajee RL, Bohnert ASB, Cunningham RM, Carter PM. Prevalence and Predictors of Driving after Prescription Opioid Use in an Adult ED Sample. The western journal of emergency medicine. 2020 Jun 19; 21(4):831-840.
  249. Baldassarri SR, Beitel M, Zinchuk A, Redeker NS, Oberleitner DE, Oberleitner LMS, Carrasco D, Madden LM, Lipkind N, Fiellin DA, Bastian LA, Chen K, Yaggi HK, Barry DT. Correlates of sleep quality and excessive daytime sleepiness in people with opioid use disorder receiving methadone treatment. Sleep & Breathing = Schlaf & Atmung. 2020 Dec 1; 24(4):1729-1737.
  250. Vu JV, Cron DC, Lee JS, Gunaseelan V, Lagisetty P, Wixson M, Englesbe MJ, Brummett CM, Waljee JF. Classifying Preoperative Opioid Use for Surgical Care. Annals of surgery. 2020 Jun 1; 271(6):1080-1086.
  251. Timko C, Hoggatt K. Commentary on Gibson et al. (2020): Medications for opioid use disorder- access, retention, and safety. Addiction (Abingdon, England). 2020 Nov 1; 115(11):2077-2078.
  252. Hand Surgery Quality Consortium. Quality Measures to Reduce Opioid Use After Common Soft Tissue Hand and Wrist Procedures. The Journal of hand surgery. 2020 Jul 1; 45(7):582-588.e4.
  253. Maciejewski ML, Smith VA, Berkowitz TSZ, Arterburn DE, Bradley KA, Olsen MK, Liu CF, Livingston EH, Funk LM, Mitchell JE. Long-term opioid use after bariatric surgery. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery. 2020 Aug 1; 16(8):1100-1110.
  254. Edelman EJ, Li Y, Barry D, Brennan Braden J, Crystal S, Kerns RD, Gaither JR, Gordon KS, Manhapra A, Merlin JS, Moore BA, Oldfield BJ, Park LS, Rentsch CT, Skanderson M, Williams EC, Justice AC, Tate JP, Becker WC, Marshall BDL. Trajectories of Self-Reported Opioid Use Among Patients With HIV Engaged in Care: Results From a National Cohort Study. Journal of acquired immune deficiency syndromes (1999). 2020 May 1; 84(1):26-36.
  255. Hadlandsmyth K, Mosher HJ, Vander Weg MW, O'Shea AM, McCoy KD, Lund BC. Utility of accumulated opioid supply days and individual patient factors in predicting probability of transitioning to long-term opioid use: An observational study in the Veterans Health Administration. Pharmacology research & perspectives. 2020 Apr 1; 8(2):e00571.
  256. Stokes A, Lundberg DJ, Hempstead K, Berry KM, Baker JF, Preston SH. Obesity and Incident Prescription Opioid Use in the U.S., 2000-2015. American journal of preventive medicine. 2020 Jun 1; 58(6):766-775.
  257. Peahl AF, Morgan DM, Dalton VK, Zivin K, Lai YL, Hu HM, Langen E, Low LK, Brummett CM, Waljee JF, Bauer ME. New persistent opioid use after acute opioid prescribing in pregnancy: a nationwide analysis. American journal of obstetrics and gynecology. 2020 Oct 1; 223(4):566.e1-566.e13.
  258. Marcial LH, Blumenfeld B, Harle C, Jing X, Keller MS, Lee V, Lin Z, Dover A, Midboe AM, Al-Showk S, Bradley V, Breen J, Fadden M, Lomotan E, Marco-Ruiz L, Mohamed R, O'Connor P, Rosendale D, Solomon H, Kawamoto K. Barriers, Facilitators, and Potential Solutions to Advancing Interoperable Clinical Decision Support: Multi-Stakeholder Consensus Recommendations for the Opioid Use Case. AMIA ... Annual Symposium proceedings. AMIA Symposium. 2020 Mar 4; 2019:637-646.
  259. Jones AL, Kertesz SG, Hausmann LRM, Mor MK, Suo Y, Pettey WBP, Schaefer JH, Gundlapalli AV, Gordon AJ. Primary care experiences of veterans with opioid use disorder in the Veterans Health Administration. Journal of substance abuse treatment. 2020 Jun 1; 113:107996.
  260. Moon AM, Jiang Y, Rogal SS, Becker J, Barritt AS. In inpatients with cirrhosis opioid use is common and associated with length of stay and persistent use post-discharge. PLoS ONE. 2020 Feb 26; 15(2):e0229497.
  261. Polimanti R, Walters RK, Johnson EC, McClintick JN, Adkins AE, Adkins DE, Bacanu SA, Bierut LJ, Bigdeli TB, Brown S, Bucholz KK, Copeland WE, Costello EJ, Degenhardt L, Farrer LA, Foroud TM, Fox L, Goate AM, Grucza R, Hack LM, Hancock DB, Hartz SM, Heath AC, Hewitt JK, Hopfer CJ, Johnson EO, Kendler KS, Kranzler HR, Krauter K, Lai D, Madden PAF, Martin NG, Maes HH, Nelson EC, Peterson RE, Porjesz B, Riley BP, Saccone N, Stallings M, Wall TL, Webb BT, Wetherill L, Psychiatric Genomics Consortium Substance Use Disorders Workgroup, Edenberg HJ, Agrawal A, Gelernter J. Leveraging genome-wide data to investigate differences between opioid use vs. opioid dependence in 41,176 individuals from the Psychiatric Genomics Consortium. Molecular Psychiatry. 2020 Aug 1; 25(8):1673-1687.
  262. Melnick ER, Nath B, Ahmed OM, Brandt C, Chartash D, Dziura JD, Hess EP, Holland WC, Hoppe JA, Jeffery MM, Katsovich L, Li F, Lu CC, Maciejewski K, Maleska M, Mao JA, Martel S, Michael S, Paek H, Patel MD, Platts-Mills TF, Rajeevan H, Ray JM, Skains RM, Soares WE, Deutsch A, Solad Y, D'Onofrio G. Progress Report on EMBED: A Pragmatic Trial of User-Centered Clinical Decision Support to Implement EMergency Department-Initiated BuprenorphinE for Opioid Use Disorder. Journal of psychiatry and brain science. 2020 Feb 21; 5.
  263. Brunet N, Moore DT, Lendvai Wischik D, Mattocks KM, Rosen MI. Increasing buprenorphine access for veterans with opioid use disorder in rural clinics using telemedicine. Substance Abuse. 2020 Feb 20; 1-8.
  264. Zullo AR, Moyo P, Jutkowitz E, Zhang W, Thomas KS. Opioid Use Disorder Among Hospitalized Older Adults: Prevalence, Characteristics, and Discharge Status. Journal of The American Medical Directors Association. 2020 Apr 1; 21(4):557-559.
  265. Acharya M, Chopra D, Hayes CJ, Teeter B, Martin BC. Cost-Effectiveness of Intranasal Naloxone Distribution to High-Risk Prescription Opioid Users. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2020 Apr 1; 23(4):451-460.
  266. Hung A, Bush C, Greiner M, Campbell H, Hammill B, Maciejewski ML, McKethan A. Risk Factors and Outcomes of Opioid Users with and Without Concurrent Benzodiazepine Use in the North Carolina Medicaid Population. Journal of managed care & specialty pharmacy. 2020 Feb 1; 26(2):169-175.
  267. Essien UR, Sileanu FE, Zhao X, Liebschutz JM, Thorpe CT, Good CB, Mor MK, Radomski TR, Hausmann LRM, Fine MJ, Gellad WF. Racial/Ethnic Differences in the Medical Treatment of Opioid Use Disorders Within the VA Healthcare System Following Non-Fatal Opioid Overdose. Journal of general internal medicine. 2020 May 1; 35(5):1537-1544.
  268. Frank JW, Binswanger IA. Commentary on Rhee & Rosenheck (2019): Buprenorphine prescribing for opioid use disorder in medical practice - can office-based out-patient care address the opiate crisis in the United States?. [Letter to the Editor]. Addiction (Abingdon, England). 2020 Apr 1; 115(4):786-787.
  269. Kilaru AS, Perrone J, Kelley D, Siegel S, Lubitz SF, Mitra N, Meisel ZF. Participation in a Hospital Incentive Program for Follow-up Treatment for Opioid Use Disorder. JAMA Network Open. 2020 Jan 3; 3(1):e1918511.
  270. Cochran G, Bruneau J, Cox N, Gordon AJ. Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic. Substance Abuse. 2020 Jan 1; 41(3):269-274.
  271. Gordon AJ, Drexler K, Hawkins EJ, Burden J, Codell NK, Mhatre-Owens A, Dungan MT, Hagedorn H. Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities. Substance Abuse. 2020 Jan 1; 41(3):275-282.
  272. Burke LG, Zhou X, Boyle KL, Orav EJ, Bernson D, Hood ME, Land T, Bharel M, Frakt AB. Trends in opioid use disorder and overdose among opioid-naive individuals receiving an opioid prescription in Massachusetts from 2011 to 2014. Addiction (Abingdon, England). 2020 Mar 1; 115(3):493-504.
  273. Pritchard ER, Dayer L, Belz J, Forseth B, Harrington SE, Painter JT. Effect of cannabis on opioid use in patients with cancer receiving palliative care. Journal of the American Pharmacists Association : JAPhA. 2020 Jan 1; 60(1):244-247.
  274. Turvey CL, Lund BC, Jones D, Arndt S. Community Treatment for Opioid Use Disorders in Urban and Rural Veterans. The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association. 2020 Mar 1; 36(2):167-176.
  275. Jasuja GK, Ameli O, Reisman JI, Rose AJ, Miller DR, Berlowitz DR, Bhasin S. Health Outcomes Among Long-term Opioid Users With Testosterone Prescription in the Veterans Health Administration. JAMA Network Open. 2019 Dec 2; 2(12):e1917141.
  276. Lapham G, Boudreau DM, Johnson EA, Bobb JF, Matthews AG, McCormack J, Liu D, Samet JH, Saxon AJ, Campbell CI, Glass JE, Rossom RC, Murphy MT, Binswanger IA, Yarborough BJH, Bradley KA, PROUD Collaborative Investigators. Prevalence and treatment of opioid use disorders among primary care patients in six health systems. Drug and Alcohol Dependence. 2020 Feb 1; 207:107732.
  277. Krause JS, Dismuke-Greer CE, Reed KS, Li C. Employment status, hours working, and gainful earnings after spinal cord injury: relationship with pain, prescription medications for pain, and nonprescription opioid use. Spinal Cord. 2020 Mar 1; 58(3):275-283.
  278. Mooney LJ, Valdez J, Cousins SJ, Yoo C, Zhu Y, Hser YI. Patient decision aid for medication treatment for opioid use disorder (PtDA-MOUD): Rationale, methodology, and preliminary results. Journal of substance abuse treatment. 2020 Jan 1; 108:115-122.
  279. Derefinko KJ, Salgado García FI, Johnson KC, Hand S, Murphy JG, McDevitt-Murphy M, Suda KJ, Andrasik F, Bursac Z, Chiu CY, Talley K, Brooks JH. A randomized pilot program to reduce opioid use following dental surgery and increase safe medication return. Addictive Behaviors. 2020 Mar 1; 102:106190.
  280. Maruti S, Desjardins I, Bagge CL, Althoff RR. Commentary: Opioid use disorder and suicide: An important opportunity to address two significant public health epidemics. Preventive medicine. 2019 Nov 1; 128:105854.
  281. Wang MC, Lozen AM, Laud PW, Nattinger AB, Krebs EE. Factors associated with chronic opioid use after cervical spine surgery for degenerative conditions. Journal of neurosurgery. Spine. 2019 Oct 11; 1-8.
  282. Shover CL, Humphreys K. Predictors of availability of long-acting medication for opioid use disorder. Drug and Alcohol Dependence. 2019 Nov 1; 204:107586.
  283. Evans EA, Yoo C, Huang D, Saxon AJ, Hser YI. Effects of access barriers and medication acceptability on buprenorphine-naloxone treatment utilization over 2?years: Results from a multisite randomized trial of adults with opioid use disorder. Journal of substance abuse treatment. 2019 Nov 1; 106:19-28.
  284. Mackey K, Veazie S, Anderson J, Bourne D, Peterson K. Evidence Brief: Barriers and Facilitators to Use of Medications for Opioid Use Disorder. 2019 Aug 1.
  285. Veazie S, Mackey K, Bourne D, Peterson K. Evidence Brief: Managing Acute Pain in Patients with Opioid Use Disorder on Medication-assisted Treatment. 2019 Aug 1.
  286. Gonzales-Castaneda R, Mooney LJ, Rawson RA. Medications for Maintenance Treatment of Opioid Use Disorder in Adolescents: A Narrative Review and Assessment of Clinical Benefits and Potential Risks, Offering a Public Health Perspective-A Commentary on Camenga et al. Journal of studies on alcohol and drugs. 2019 Jul 1; 80(4):403-405.
  287. Vest N, Humphreys KN. Do We Know Enough to Prescribe Opioid-Agonist Therapies to Adolescents With Problematic Opioid Use? A Commentary on Camenga et al. (2019). Journal of studies on alcohol and drugs. 2019 Jul 1; 80(4):406-407.
  288. Hernandez-Boussard T, Graham LA, Carroll I, Dasinger EA, Titan AL, Morris MS, Hawn MT. Perioperative opioid use and pain-related outcomes in the Veterans Health Administration. American journal of surgery. 2020 Jun 1; 219(6):969-975.
  289. McGuire AB, Powell KG, Treitler PC, Wagner KD, Smith KP, Cooperman N, Robinson L, Carter J, Ray B, Watson DP. Emergency department-based peer support for opioid use disorder: Emergent functions and forms. Journal of substance abuse treatment. 2020 Jan 1; 108:82-87.
  290. Larochelle MR, Bohnert ASB. Opportunities to Address First Opioid Prescriptions to Reduce Incident Long-Term Opioid Use. Annals of internal medicine. 2019 Jul 16; 171(2):129-130.
  291. Tas B, Humphreys K, McDonald R, Strang J. Should we worry that take-home naloxone availability may increase opioid use? Addiction (Abingdon, England). 2019 Oct 1; 114(10):1723-1725.
  292. Wolk CB, Doubeni CA, Klusaritz HA, Bilger A, Paterson E, Oslin DW. Perspectives and Practice in the Identification and Treatment of Opioid Use, Alcohol Use, and Depressive Disorders. Psychiatric services (Washington, D.C.). 2019 Oct 1; 70(10):940-943.
  293. Haffajee RL, Lin LA, Bohnert ASB, Goldstick JE. Characteristics of US Counties With High Opioid Overdose Mortality and Low Capacity to Deliver Medications for Opioid Use Disorder. JAMA Network Open. 2019 Jun 5; 2(6):e196373.
  294. Duncan MH, Ratzliff AD, Powers DM, Banta-Green CJ, Saxon AJ. The Next Stage of Buprenorphine Care for Opioid Use Disorder. Annals of internal medicine. 2019 Jun 4; 170(11):820-821.
  295. Lagisetty PA, Bohnert A. Role of an Accurate Treatment Locator and Cash-Only Practices in Access to Buprenorphine for Opioid Use Disorders. [Editorial]. Annals of internal medicine. 2019 Jul 2; 171(1):58-59.
  296. Mudumbai SC, Lewis ET, Oliva EM, Chung PD, Harris B, Trafton J, Mariano ER, Wagner T, Clark JD, Stafford RS. Overdose Risk Associated with Opioid Use upon Hospital Discharge in Veterans Health Administration Surgical Patients. Pain medicine (Malden, Mass.). 2019 May 1; 20(5):1020-1031.
  297. Harbaugh CM, Lee JS, Chua KP, Kenney B, Iwashyna TJ, Englesbe MJ, Brummett CM, Bohnert AS, Waljee JF. Association Between Long-term Opioid Use in Family Members and Persistent Opioid Use After Surgery Among Adolescents and Young Adults. JAMA surgery. 2019 Apr 17; 154(4):e185838.
  298. Bohnert ASB, Ilgen MA. Understanding Links among Opioid Use, Overdose, and Suicide. Reply. [Letter to the Editor]. The New England journal of medicine. 2019 Apr 4; 380(14):1380.
  299. Cole ES, DiDomenico E, Cochran G, Gordon AJ, Gellad WF, Pringle J, Warwick J, Chang CH, Kim JY, Kmiec J, Kelley D, Donohue JM. The Role of Primary Care in Improving Access to Medication-Assisted Treatment for Rural Medicaid Enrollees with Opioid Use Disorder. Journal of general internal medicine. 2019 Jun 1; 34(6):936-943.
  300. Brummett CM, Moser SE, Nallamothu BK. Errors in Analysis in Study of New Persistent Opioid Use After Surgery. JAMA surgery. 2019 Mar 1; 154(3):268-269.
  301. Dasinger EA, Graham LA, Wahl TS, Richman JS, Baker SJ, Hawn MT, Hernandez-Boussard T, Rosen AK, Mull HJ, Copeland LA, Whittle JC, Burns EA, Morris MS. Preoperative opioid use and postoperative pain associated with surgical readmissions. American journal of surgery. 2019 Nov 1; 218(5):828-835.
  302. Kumthekar A, Shull S, Lovejoy TI, Morasco BJ, Chang M, Barton J. Impact of hepatitis C treatment on pain intensity, prescription opioid use and arthritis. International journal of rheumatic diseases. 2019 Apr 1; 22(4):592-598.
  303. Shah A, Hayes CJ, Lakkad M, Martin BC. Impact of Medical Marijuana Legalization on Opioid Use, Chronic Opioid Use, and High-risk Opioid Use. Journal of general internal medicine. 2019 Aug 1; 34(8):1419-1426.
  304. Dasinger EA, Branch-Elliman W, Pizer SD, Abdulkerim H, Rosen AK, Charns MP, Hawn MT, Itani KMF, Mull HJ. Association between postoperative opioid use and outpatient surgical adverse events. American journal of surgery. 2019 Apr 1; 217(4):605-612.
  305. Bohnert ASB, Ilgen MA. Understanding Links among Opioid Use, Overdose, and Suicide. The New England journal of medicine. 2019 Jan 3; 380(1):71-79.
  306. Hser YI, Saxon AJ, Mooney LJ, Miotto K, Zhu Y, Yoo CK, Liang D, Huang D, Bell DS. Escalating Opioid Dose Is Associated With Mortality: A Comparison of Patients With and Without Opioid Use Disorder. Journal of addiction medicine. 2019 Jan 1; 13(1):41-46.
  307. Dayer LE, Painter JT, McCain K, King J, Cullen J, Foster HR. A recent history of opioid use in the US: Three decades of change. Substance use & misuse. 2018 Dec 21; 54(2):331-339.
  308. Hagedorn H, Kenny M, Gordon AJ, Ackland PE, Noorbaloochi S, Yu W, Harris AHS. Advancing pharmacological treatments for opioid use disorder (ADaPT-OUD): protocol for testing a novel strategy to improve implementation of medication-assisted treatment for veterans with opioid use disorders in low-performing facilities. Addiction science & clinical practice. 2018 Dec 13; 13(1):25.
  309. Noureldin M, Higgins PDR, Govani SM, Cohen-Mekelburg S, Kenney BC, Stidham RW, Waljee JF, Waljee AK. Incidence and predictors of new persistent opioid use following inflammatory bowel disease flares treated with oral corticosteroids. Alimentary pharmacology & therapeutics. 2019 Jan 1; 49(1):74-83.
  310. Finlay AK, Wong JJ, Ellerbe LS, Rubinsky A, Gupta S, Bowe TR, Schmidt EM, Timko C, Burden JL, Harris AHS. Barriers and Facilitators to Implementation of Pharmacotherapy for Opioid Use Disorders in VHA Residential Treatment Programs. Journal of studies on alcohol and drugs. 2018 Nov 1; 79(6):909-917.
  311. Finlay AK, Binswanger IA, Timko C, Smelson D, Stimmel MA, Yu M, Bowe T, Harris AHS. Facility-level changes in receipt of pharmacotherapy for opioid use disorder: Implications for implementation science. Journal of substance abuse treatment. 2018 Dec 1; 95:43-47.
  312. Meshberg-Cohen S, Black AC, DeViva JC, Petrakis IL, Rosen MI. Trauma treatment for veterans in buprenorphine maintenance treatment for opioid use disorder. Addictive Behaviors. 2019 Feb 1; 89:29-34.
  313. Herzig SJ, Mosher HJ, Calcaterra SL, Nuckols TK. Reply to "In Reference to 'Improving the Safety of Opioid Use for Acute Noncancer Pain in Hospitalized Adults: A Consensus Statement from the Society of Hospital Medicine'". Journal of hospital medicine. 2018 Sep 1; 13(10):728.
  314. Lisi AJ, Corcoran KL, DeRycke EC, Bastian LA, Becker WC, Edmond SN, Goertz CM, Goulet JL, Haskell SG, Higgins DM, Kawecki T, Kerns RD, Mattocks K, Ramsey C, Ruser CB, Brandt CA. Opioid Use Among Veterans of Recent Wars Receiving Veterans Affairs Chiropractic Care. Pain medicine (Malden, Mass.). 2018 Sep 1; 19(suppl_1):S54-S60.
  315. Riddle DL, Slover JD, Ang DC, Bair MJ, Kroenke K, Perera RA, Dumenci L. Opioid use prior to knee arthroplasty in patients who catastrophize about their pain: preoperative data from a multisite randomized clinical trial. Journal of pain research. 2018 Aug 21; 11:1549-1557.
  316. Hayes CJ, Payakachat N, Li C. Evaluation of opioid use among patients with back disorders and arthritis. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2018 Nov 1; 27(11):3021-3035.
  317. Giannitrapani KF, Ahluwalia SC, McCaa M, Pisciotta M, Dobscha S, Lorenz KA. Barriers to Using Nonpharmacologic Approaches and Reducing Opioid Use in Primary Care. Pain medicine (Malden, Mass.). 2018 Jul 1; 19(7):1357-1364.
  318. Darnall BD, Humphreys KN. An experimental method for assessing whether marijuana use reduces opioid use in patients with chronic pain. [Letter to the Editor]. Addiction (Abingdon, England). 2018 Aug 1; 113(8):1552-1553.
  319. Minegishi T, Frakt A. Reducing Long-term Opioid Use in the Veterans Health Administration. [Editorial]. Journal of general internal medicine. 2018 Jun 1; 33(6):781-782.
  320. Saraswathula A, Chen MM, Mudumbai SC, Whittemore AS, Divi V. Persistent Postoperative Opioid Use in Older Head and Neck Cancer Patients. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 2019 Mar 1; 160(3):380-387.
  321. Dindo L, Zimmerman MB, Hadlandsmyth K, StMarie B, Embree J, Marchman J, Tripp-Reimer T, Rakel B. Acceptance and Commitment Therapy for Prevention of Chronic Postsurgical Pain and Opioid Use in At-Risk Veterans: A Pilot Randomized Controlled Study. The journal of pain : official journal of the American Pain Society. 2018 Oct 1; 19(10):1211-1221.
  322. Herzig SJ, Mosher HJ, Calcaterra SL, Jena AB, Nuckols TK. Improving the Safety of Opioid Use for Acute Noncancer Pain in Hospitalized Adults: A Consensus Statement From the Society of Hospital Medicine. Journal of hospital medicine. 2018 Apr 1; 13(4):263-271.
  323. Mosher HJ, Hofmeyer BA, Hadlandsmyth K, Richardson KK, Lund BC. Predictors of Long-Term Opioid Use After Opioid Initiation at Discharge From Medical and Surgical Hospitalizations. Journal of hospital medicine. 2018 Apr 1; 13(4):243-248.
  324. Saxon AJ, Akerman SC, Liu CC, Sullivan MA, Silverman BL, Vocci FJ. Extended-release naltrexone (XR-NTX) for opioid use disorder in clinical practice: Vivitrol's Cost and Treatment Outcomes Registry. Addiction (Abingdon, England). 2018 Aug 1; 113(8):1477-1487.
  325. Raffel KE, Beach LY, Lin J, Berchuck JE, Abram S, Markle E, Patel S. Naloxone Distribution and Training for Patients with High-Risk Opioid Use in a Veterans Affairs Community-Based Primary Care Clinic. The Permanente journal. 2018 Mar 30; 22.
  326. Gressler LE, Martin BC, Hudson TJ, Painter JT. Relationship between concomitant benzodiazepine-opioid use and adverse outcomes among US veterans. Pain. 2018 Mar 1; 159(3):451-459.
  327. Hayes CJ, Li X, Li C, Shah A, Kathe N, Bhandari NR, Payakachat N. Health-Related Quality of Life among Chronic Opioid Users, Nonchronic Opioid Users, and Nonopioid Users with Chronic Noncancer Pain. Health services research. 2018 Oct 1; 53(5):3329-3349.
  328. Wyse JJ, Gordon AJ, Dobscha SK, Morasco BJ, Tiffany E, Drexler K, Sandbrink F, Lovejoy TI. Medications for opioid use disorder in the Department of Veterans Affairs (VA) health care system: Historical perspective, lessons learned, and next steps. Substance Abuse. 2018 Jan 1; 39(2):139-144.
  329. Gellad WF, Thorpe JM, Zhao X, Thorpe CT, Sileanu FE, Cashy JP, Hale JA, Mor MK, Radomski TR, Hausmann LRM, Donohue JM, Gordon AJ, Suda KJ, Stroupe KT, Hanlon JT, Cunningham FE, Good CB, Fine MJ. Impact of Dual Use of Department of Veterans Affairs and Medicare Part D Drug Benefits on Potentially Unsafe Opioid Use. American journal of public health. 2018 Feb 1; 108(2):248-255.
  330. Abraham AJ, Andrews CM, Grogan CM, Pollack HA, D'Aunno T, Humphreys K, Friedmann PD. State-Targeted Funding and Technical Assistance to Increase Access to Medication Treatment for Opioid Use Disorder. Psychiatric services (Washington, D.C.). 2018 Apr 1; 69(4):448-455.
  331. Lagisetty P, Klasa K, Bush C, Heisler M, Chopra V, Bohnert A. Primary care models for treating opioid use disorders: What actually works? A systematic review. PLoS ONE. 2017 Oct 17; 12(10):e0186315.
  332. Lovejoy TI, Morasco BJ, Kumthekar A, Shull S, Chang M, Barton J. Eradication of hepatitis C among US veterans: examination of changes in pain severity and prescription opioid use following treatment. [Abstract]. Arthritis + Rheuma.. 2017 Sep 27; 69(10):2221.
  333. Hadlandsmyth K, Vander Weg MW, McCoy KD, Mosher HJ, Vaughan-Sarrazin MS, Lund BC. Risk for Prolonged Opioid Use Following Total Knee Arthroplasty in Veterans. Journal of Arthroplasty. 2018 Jan 1; 33(1):119-123.
  334. Frazier W, Cochran G, Lo-Ciganic WH, Gellad WF, Gordon AJ, Chang CH, Donohue JM. Medication-Assisted Treatment and Opioid Use Before and After Overdose in Pennsylvania Medicaid. [Letter to the Editor]. JAMA : the journal of the American Medical Association. 2017 Aug 22; 318(8):750-752.
  335. Watkins KE, Paddock SM, Hudson TJ, Ounpraseuth S, Schrader AM, Hepner KA, Stein BD. Association between process measures and mortality in individuals with opioid use disorders. Drug and Alcohol Dependence. 2017 Aug 1; 177:307-314.
  336. Brummett CM, Waljee JF, Goesling J, Moser S, Lin P, Englesbe MJ, Bohnert ASB, Kheterpal S, Nallamothu BK. New Persistent Opioid Use After Minor and Major Surgical Procedures in US Adults. JAMA surgery. 2017 Jun 21; 152(6):e170504.
  337. Hudson TJ, Painter JT, Martin BC, Austen MA, Williams JS, Fortney JC, Sullivan MD, Edlund MJ. Pharmacoepidemiologic analyses of opioid use among OEF/OIF/OND veterans. Pain. 2017 Jun 1; 158(6):1039-1045.
  338. Demidenko MI, Dobscha SK, Morasco BJ, Meath THA, Ilgen MA, Lovejoy TI. Suicidal ideation and suicidal self-directed violence following clinician-initiated prescription opioid discontinuation among long-term opioid users. General hospital psychiatry. 2017 Jul 1; 47:29-35.
  339. Lovejoy TI, Demidenko MI, Morasco BJ, Meath T, Dobscha SK. Suicidal ideation and behaviors following clinician-initiated prescription opioid discontinuation among long-term opioid users. [Abstract]. The journal of pain : official journal of the American Pain Society. 2017 Apr 1; 18(4):S36.
  340. Hanks D. QUERI e-News-1: Pain Management and Opioid Use. [Newsletter] 2017 Feb 28. 9 (1). Available from: https://www.queri.research.va.gov/qnews/feb17/default.cfm.
  341. Krebs E, Urada D, Evans E, Huang D, Hser YI, Nosyk B. The costs of crime during and after publicly funded treatment for opioid use disorders: a population-level study for the state of California. Addiction (Abingdon, England). 2017 May 1; 112(5):838-851.
  342. Stein BD, Mendelsohn J, Gordon AJ, Dick AW, Burns RM, Sorbero M, Shih RA, Liccardo Pacula R. Opioid analgesic and benzodiazepine prescribing among Medicaid-enrollees with opioid use disorders: The influence of provider communities. Journal of addictive diseases. 2017 Jan 1; 36(1):14-22.
  343. Krebs E, Min JE, Evans E, Li L, Liu L, Huang D, Urada D, Kerr T, Hser YI, Nosyk B. Estimating State Transitions for Opioid Use Disorders. Medical Decision Making. 2017 Jul 1; 37(5):483-497.
  344. Ducoffe AR, York A, Hu DJ, Perfetto D, Kerns RD. National Action Plan for Adverse Drug Event Prevention: Recommendations for Safer Outpatient Opioid Use. Pain medicine (Malden, Mass.). 2016 Dec 1; 17(12):2291-2304.
  345. Grogan CM, Andrews C, Abraham A, Humphreys K, Pollack HA, Smith BT, Friedmann PD. Survey Highlights Differences In Medicaid Coverage For Substance Use Treatment And Opioid Use Disorder Medications. Health affairs (Project Hope). 2016 Dec 1; 35(12):2289-2296.
  346. Moore BA, Fiellin DA, Cutter CJ, Buono FD, Barry DT, Fiellin LE, O'Connor PG, Schottenfeld RS. Cognitive Behavioral Therapy Improves Treatment Outcomes for Prescription Opioid Users in Primary Care Buprenorphine Treatment. Journal of substance abuse treatment. 2016 Dec 1; 71:54-57.
  347. Bastian LA. Cigarette Smoking as a Risk Factor for Chronic Opioid Use. Spotlight on Pain Management [Cyberseminar]. 2016 Nov 1.
  348. Rogal S, Mankaney G, Udawatta V, Good CB, Chinman M, Zickmund S, Bielefeldt K, Jonassaint N, Jazwinski A, Shaikh O, Hughes C, Humar A, DiMartini A, Fine MJ. Association between opioid use and readmission following liver transplantation. Clinical Transplantation. 2016 Oct 1; 30(10):1222-1229.
  349. Stein BD, Sorbero M, Dick AW, Pacula RL, Burns RM, Gordon AJ. Physician Capacity to Treat Opioid Use Disorder With Buprenorphine-Assisted Treatment. JAMA. 2016 Sep 20; 316(11):1211-1212.
  350. Seal KH, Maguen S, Bertenthal D, Batki SL, Striebel J, Stein MB, Madden E, Neylan TC. Observational Evidence for Buprenorphine's Impact on Posttraumatic Stress Symptoms in Veterans With Chronic Pain and Opioid Use Disorder. The Journal of clinical psychiatry. 2016 Sep 1; 77(9):1182-1188.
  351. Tetrault JM, Tate JP, Edelman EJ, Gordon AJ, Lo Re V, Lim JK, Rimland D, Goulet J, Crystal S, Gaither JR, Gibert CL, Rodriguez-Barradas MC, Fiellin LE, Bryant K, Justice AC, Fiellin DA. Hepatic Safety of Buprenorphine in HIV-Infected and Uninfected Patients With Opioid Use Disorder: The Role of HCV-Infection. Journal of substance abuse treatment. 2016 Sep 1; 68:62-7.
  352. Hanks D. In Progress-2: Improving the Safety of Prescription Opioid Use among Veterans. 2016 Aug 3; 1(2).
  353. Barry DT, Sofuoglu M, Kerns RD, Wiechers IR, Rosenheck RA. Prevalence and correlates of coprescribing anxiolytic medications with extensive prescription opioid use in Veterans Health Administration patients with metastatic cancer. Journal of opioid management. 2016 Jul 1; 12(4):259-68.
  354. Krebs EE, Kroenke K, Wu J, Bair MJ, Kozak MA, Yu Z. Opioid Use as a Predictor of Health Care Use and Pain Outcomes: Analysis of Clinical Trial Data. Pain medicine (Malden, Mass.). 2016 Jul 1; 17(7):1261-1268.
  355. Calcaterra SL, Yamashita TE, Min SJ, Keniston A, Frank JW, Binswanger IA. Opioid Prescribing at Hospital Discharge Contributes to Chronic Opioid Use. Journal of general internal medicine. 2016 May 1; 31(5):478-85.
  356. Diulio AR, Demidenko MI, Lovejoy TI. Multidisciplinary pain clinics, in Treating comorbid opioid use disorder and dependence in chronic pain. Ed. Matthews, AM. Springer International Publishing, 2016: pp. 177-184. SpringerPlus. 2016 Apr 30.
  357. Finlay AK, Binswanger I, Timko C, Rosenthal J, Clark S, Blue-Howells J, McGuire J, Hagedorn H, Wong J, Van Campen J, Sox-Harris AH. Receipt of pharmacotherapy for opioid use disorder by justice-involved U.S. Veterans Health Administration patients. Drug and Alcohol Dependence. Paper presented at: Academic and Health Policy Conference on Correctional Health; 2016 Mar 18; Baltimore, MD.
  358. Finlay AK, Harris AH, Rosenthal J, Blue-Howells J, Clark S, McGuire J, Timko C, Frayne SM, Smelson D, Oliva E, Binswanger I. Receipt of pharmacotherapy for opioid use disorder by justice-involved U.S. Veterans Health Administration patients. Drug and Alcohol Dependence. 2016 Mar 1; 160:222-6.
  359. Krein SL, Bohnert A, Kim HM, Harris ME, Richardson CR. Opioid use and walking among patients with chronic low back pain. Journal of rehabilitation research and development. 2016 Feb 1; 53(1):107-16.
  360. Burns RM, Pacula RL, Bauhoff S, Gordon AJ, Hendrikson H, Leslie DL, Stein BD. Policies Related To Opioid Agonist Therapy for Opioid Use Disorders: The Evolution of State Policies from 2004 to 2013. Substance Abuse. 2015 Nov 13; 37(1):63-9.
  361. Bachhuber MA, Roberts CB, Metraux S, Montgomery AE. Screening for homelessness among individuals initiating medication-assisted treatment for opioid use disorder in the Veterans Health Administration. Journal of opioid management. 2015 Nov 1; 11(6):459-62.
  362. Hayes CJ, Hudson TJ, Phillips MM, Bursac Z, Williams JS, Austin MA, Edlund MJ, Martin BC. The influence of propoxyphene withdrawal on opioid use in veterans. Pharmacoepidemiology and drug safety. 2015 Nov 1; 24(11):1180-8.
  363. Pacula RL, Stein B, Gordon AJ, Dick A, Burns RM, Leslie DL, Sorbero MS. The Impact of State Policies on the Use of Buprenorphine Among Medicaid Enrollees Identified with Opioid Use Disorders. Paper presented at: Addiction Health Services Research Conference; 2015 Oct 16; Marina del Rey, CA.
  364. Stein B, Paula RL, Sorbero M, Gordon AJ, Leslie DL, Burns RM, Shih RA, Dick AW. Disparities in Opioid Agonist Therapy by Race/Ethnicity and HIV Status Among Medicaid-Enrollees with Opioid Use Disorders. Paper presented at: Addiction Health Services Research Conference; 2015 Oct 16; Marina del Rey, CA.
  365. Finlay AK, Bowe T, Sox-Harris AH. Changes in receipt of pharmacotherapy for opioid use disorder among veterans from fiscal years 2012-2013. Paper presented at: Addiction Health Services Research Conference; 2015 Oct 15; Marina del Rey, CA.
  366. Stein BD, Mendelsohn J, Gordon A, Pacula RL, Burns RM, Sorbero M, Dick A. Physician Community Network Structure and Clinically Questionable Prescribing Practices for Medicaid-Enrollees With Opioid Use Disorder. Paper presented at: Addiction Health Services Research Conference; 2015 Oct 15; Marina Del Rey, CA.
  367. Stein BD, Pacula RL, Gordon AJ, Burns RM, Leslie DL, Sorbero MJ, Bauhoff S, Mandell TW, Dick AW. Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties. The Milbank Quarterly. 2015 Sep 1; 93(3):561-83.
  368. Suda KJ, Bailey LA, Smith BM, Gellad WF, Huo Z, Cunningham F, Burk M, Stroupe KT. Opioid use in Veterans eligible for VA and Medicare Part D and predictors for overlap within and among VA and Medicare Part D-reimbursed pharmacies. Poster session presented at: VA HSR&D / QUERI National Meeting; 2015 Jul 9; Philadelphia, PA.
  369. Finlay AK, Harris A, Blue-Howells J, Rosenthal J, McGuire J, Binswanger I. Receipt of pharmacotherapy for opioid use disorder: Comparing Justice-involved Veterans with Other Veterans. Poster session presented at: VA HSR&D / QUERI National Meeting; 2015 Jul 8; Philadelphia, PA.
  370. Barry DT, Sofuoglu M, Kerns RD, Wiechers IR, Rosenheck RA. Prevalence and correlates of co-prescribing psychotropic medications with long-term opioid use nationally in the Veterans Health Administration. Psychiatry Research. 2015 Jun 30; 227(2-3):324-32.
  371. Finlay AK, Harris A, Blue-Howells J, Rosenthal J, McGuire J, Binswanger I. Receipt of pharmacotherapy for opioid use disorder: Comparing Veterans in Veterans Justice Programs with other Veterans. Poster session presented at: AcademyHealth Annual Research Meeting; 2015 Jun 14; Minneapolis, MN.
  372. Comer S, Cunningham C, Fishman MJ, Gordon AJ, Kampman K, Langleben D, Nordstrom B, Oslin D, Woody G, Wright T, Wyatt S. American Society of Addiction Medicine National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use. 2015 May 27.
  373. Rogal SS, Bielefeldt K, Wasan AD, Lotrich FE, Zickmund S, Szigethy E, DiMartini AF. Inflammation, psychiatric symptoms, and opioid use are associated with pain and disability in patients with cirrhosis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2015 May 1; 13(5):1009-16.
  374. Becker W, Tate JP, Edelman EJ, Gaither J, Akgun K, Barry D, Crystal S, Gordon A, Merlin JS, Kerns RD, Justice AC, Fiellin DA. The Relationship Among Opioid Use, HIV, and Accidental Death: Is It In the Eye of the Beholder? Poster session presented at: Society of General Internal Medicine Annual Meeting; 2015 Apr 24; Toronto, Canada.
  375. Krebs EE, Kroenke K, Wu J, Bair MJ, Yu Z. Baseline opioid use as a predictor of telecare collaborative pain management outcomes. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2015 Apr 23; Toronto, Canada.
  376. Bohnert AS. Preventing prescription opioid overdoses: Changing prescribing practices and patients’ risky opioid use. Paper presented at: VA VISN 11 Opioid Safety Initiative and Pain Management Seminar; 2015 Apr 22; Fort Wayne, IN.
  377. Bohnert AS. Preventing prescription opioid overdoses: Changing prescribing practices and patients’ risky opioid use. Paper presented at: VA Palo Alto Center for Innovation to Implementation Seminar Series; 2015 Apr 20; Palo Alto, CA.
  378. Bohnert AS. Preventing prescription opioid overdoses: Changing prescribing practices and patients’ risky opioid use. Paper presented at: Kaiser Permanente Division of Research Annual Meeting; 2015 Apr 16; San Francisco, CA.
  379. Farmer CM, Lindsay D, Williams J, Ayers A, Schuster J, Cilia A, Flaherty MT, Mandell T, Gordon AJ, Stein BD. Practice guidance for buprenorphine for the treatment of opioid use disorders: results of an expert panel process. Substance Abuse. 2015 Apr 6; 1-8.
  380. Finlay AK, Binswanger I, Frayne SM, Harris A. Receipt of pharmacotherapy for opioid use disorder: Comparing justice-involved Veterans with other Veterans. Presented at: Academic and Health Policy Conference on Correctional Health; 2015 Mar 19; Boston, MA.
  381. Larney S, Bohnert AS, Ganoczy D, Ilgen MA, Hickman M, Blow FC, Degenhardt L. Mortality among older adults with opioid use disorders in the Veteran's Health Administration, 2000-2011. Drug and Alcohol Dependence. 2015 Feb 1; 147:32-7.
  382. Becker WC, Ganoczy D, Fiellin DA, Bohnert AS. Buprenorphine/Naloxone dose and pain intensity among individuals initiating treatment for opioid use disorder. Journal of substance abuse treatment. 2015 Jan 1; 48(1):128-31.
  383. Gordon AJ, Jenkins JA. The Time Is Now: The Role of Pharmacotherapies in Expanding Treatment for Opioid Use Disorder. [Editorial]. Substance Abuse. 2015 Jan 1; 36(2):127-8.
  384. Stein BD, Gordon AJ, Dick A, Burns RM, Pacula R, Farmer C, Leslie D. Physician supply for the treatment of opioid use disorders: the influence of state policies. [Abstract]. Drug and Alcohol Dependence. 2015 Jan 1; 146:e107-e108.
  385. Mudumbai S, Unger-Hu K, Oliva E, Lewis E, Trafton J, Mariano ER, Stafford RS, Wagner T, Clark D. Adverse Outcomes associated with Types of Postoperative Opioid Use: A Population-level Study of the Veterans Affairs Healthcare System. Paper presented at: American Society of Regional Anesthesia and Pain Medicine Annual Pain Medicine Meeting; 2014 Nov 13; San Francisco, CA.
  386. Lewis ET. What we know about opioid adherence might surprise you: findings from a qualitative study of opioid use behaviors. HSR&D Spotlight on Pain Management. [Cyberseminar]. 2014 Nov 4.
  387. Edlund MJ, Austen MA, Sullivan MD, Martin BC, Williams JS, Fortney JC, Hudson TJ. Patterns of opioid use for chronic noncancer pain in the Veterans Health Administration from 2009 to 2011. Pain. 2014 Nov 1; 155(11):2337-43.
  388. Morasco BJ, O'Hearn D, Turk DC, Dobscha SK. Associations between prescription opioid use and sleep impairment among veterans with chronic pain. Pain medicine (Malden, Mass.). 2014 Nov 1; 15(11):1902-10.
  389. Stein BD, Dick SW, Sorbero M, Burns RM, Pacula RL, Gordon AJ, Leslie DL. Patterns of buprenorphine use among Medicaid-enrolled individuals with opioid use disorders. Poster session presented at: Addiction Health Services Research Conference; 2014 Oct 16; Boston, MA.
  390. Park TW, Friedmann PD. Medications for addiction treatment: an opportunity for prescribing clinicians to facilitate remission from alcohol and opioid use disorders. Rhode Island medical journal. 2014 Oct 1; 97(10):20-4.
  391. Becker WC, Ganoczy D, Fiellin DA, Bohnert AS. Buprenorphine/naloxone dose and pain intensity among individuals initiating treatment for opioid use disorder. Poster session presented at: College on Problems of Drug Dependence Annual Meeting; 2014 Jun 19; San Juan, Puerto Rico.
  392. Stein BD, Gordon AJ, Dick A, Burns RM, Pacula R, Farmer C, Leslie D. Physician supply for the treatment of opioid use disorders: the influence of state policies. Poster session presented at: College on Problems of Drug Dependence Annual Meeting; 2014 Jun 16; San Juan, Puerto Rico.
  393. Krein SL, Bohnert AS, Kim M, Harris ME, Richardson CR. Opioid Use and Walking Among Patients with Chronic Low Back Pain. Poster session presented at: AcademyHealth Annual Research Meeting; 2014 Jun 10; San Diego, CA.
  394. Hudson TJ, Williams S, Austen MA, Martin B, Sullivan M, Fortney JC, Edlund MJ. Opioid use among OEF/OIF Veterans with Traumatic Brain Injury. Poster session presented at: AcademyHealth Annual Research Meeting; 2014 Jun 9; San Diego, CA.
  395. Krebs EE, Paudel M, Taylor BC, Bauer D, Fink HA, Lane N, Ensrud KE. Association of opioid use with falls and fractures among older men. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2014 Apr 23; San Diego, CA.
  396. Hudson TJ, Martin BC, Sullivan M, Fortney JC, Austen MA, Williams S, Edlund MJ. Population-level analysis of opioid use among Veterans. Poster session presented at: Association for Clinical Research Training / Society for Clinical and Translational Science / American Federation for Medical Research Translational Science Meeting; 2014 Apr 11; Washington, DC.
  397. Donohue JM, Lo-Ciganic WH, Cochran G, Gordon AJ, Zemaitis MA, Gellad WF. Opioid use, opioid use disorder and buprenorphine use in Pennsylvania Medicaid. Philadelphia, PA: Commonwealth of Pennsylvania Department of Public Welfare, Office of Medical Assistance Programs; 2014 Mar 31. 42 p.
  398. Bonar EE, Ilgen MA, Walton M, Bohnert AS. Associations among pain, non-medical prescription opioid use, and drug overdose history. The American journal on addictions. 2014 Jan 1; 23(1):41-7.
  399. Painter JT, Crofford LJ, Talbert J. Geographic variation of chronic opioid use in fibromyalgia. Poster session presented at: International Society for Pharmacoepidemiology Annual Conference; 2013 Nov 3; Washington, DC.
  400. Edlund MJ, Sullivan M, Martin BC, Fortney JC, Landes RD, Austen MA, Williams S, Hudson TJ. Patterns of opioid use among Veterans with chronic non-cancer pain. Paper presented at: Addiction Health Services Research Conference; 2013 Oct 25; Portland, OR.
  401. Hayes C, Phillips M, Martin BC, Bursac Z, Williams S, Hudson TJ. The influence of the propoxyphene withdrawal on opioid use and opioid related adverse events in Veterans. Paper presented at: Addiction Health Services Research Conference; 2013 Oct 25; Portland, OR.
  402. Hudson TJ, Edlund MJ, Martin BC, Sullivan M, Fortney JC, Landes RD, Austen MA, Williams S. National analysis of opioid use among Veterans. Paper presented at: Addiction Health Services Research Conference; 2013 Oct 25; Portland, OR.
  403. Hudson TJ, Pope R, Williams S, Martin BC, Sullivan M, Fortney JC, Landes RD, Edlund MJ. Opioid use among OEF/OIF/OND Veterans with traumatic brain injury. Paper presented at: Addiction Health Services Research Conference; 2013 Oct 25; Portland, OR.
  404. Roy-Byrne P, Sullivan MD, Sherbourne CD, Golinelli D, Craske MG, Sullivan G, Stein MB. Effects of pain and prescription opioid use on outcomes in a collaborative care intervention for anxiety. The Clinical Journal of Pain. 2013 Sep 1; 29(9):800-6.
  405. Bohnert AS, Eisenberg A, Whiteside L, Price A, McCabe SE, Ilgen MA. Prescription opioid use among addictions treatment patients: nonmedical use for pain relief vs. other forms of nonmedical use. Addictive Behaviors. 2013 Mar 1; 38(3):1776-81.
  406. Carbone LD, Chin AS, Lee TA, Burns SP, Svircev JN, Hoenig HM, Akhigbe T, Weaver FM. The association of opioid use with incident lower extremity fractures in spinal cord injury. The journal of spinal cord medicine. 2013 Mar 1; 36(2):91-6.
  407. Painter JT, Crofford LJ. Chronic opioid use in fibromyalgia syndrome: a clinical review. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases. 2013 Mar 1; 19(2):72-7.
  408. Painter JT, Crofford LJ, Talbert J. Geographic variation of chronic opioid use in fibromyalgia. Clinical therapeutics. 2013 Mar 1; 35(3):303-11.
  409. Dobscha SK, Morasco BJ, Duckart JP, Macey T, Deyo RA. Correlates of prescription opioid initiation and long-term opioid use in veterans with persistent pain. The Clinical Journal of Pain. 2013 Feb 1; 29(2):102-8.
  410. Dobscha SK. Critical Review of Recent Research Findings—Opioid Use and Misuse. Presented at: Academy of Psychosomatic Medicine Annual Meeting; 2012 Nov 15; Atlanta, GA.
  411. Carroll I, Barelka P, Wang CK, Wang BM, Gillespie MJ, McCue R, Younger JW, Trafton J, Humphreys K, Goodman SB, Dirbas F, Whyte RI, Donington JS, Cannon WB, Mackey SC. A pilot cohort study of the determinants of longitudinal opioid use after surgery. Anesthesia and analgesia. 2012 Sep 1; 115(3):694-702.
  412. Bohnert AS. Recent non-medical prescription opioid use among adult patients at an inner-city emergency department. Paper presented at: College on Problems of Drug Dependence Annual Meeting; 2012 Jun 11; Palm Springs, CA.
  413. Skinner MA, Lewis ET, Trafton JA. Opioid use patterns and association with pain severity and mental health functioning in chronic pain patients. Pain medicine (Malden, Mass.). 2012 Apr 1; 13(4):507-17.
  414. Seal KH, Shi Y, Cohen G, Cohen BE, Maguen S, Krebs EE, Neylan TC. Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan. JAMA. 2012 Mar 7; 307(9):940-7.
  415. Macey TA, Morasco BJ, Duckart JP, Dobscha SK. Patterns and correlates of prescription opioid use in OEF/OIF veterans with chronic noncancer pain. Pain medicine (Malden, Mass.). 2011 Oct 1; 12(10):1502-9.
  416. Carbone L, Chin A, Lee TA, Burns S, Svircev J, Hoening H, Akhigbe T, Weaver FM. Anticonvulsant and Opioid Use and Fractures in Veterans with Spinal Cord Injury. Poster session presented at: American Society for Bone and Mineral Research Annual Meeting; 2011 Sep 17; San Diego, CA.
  417. Awosika CO, Sanders SH, Clark ME, Banou E. The Effects of Opioid Use on Veterans with Primary Chronic Headaches Participating in Inpatient Chronic Pain Rehabilitation. Poster session presented at: American Headache Society Annual Meeting; 2011 Jun 4; Washington, DC.
  418. Chan G, Gelernter J, Oslin D, Farrer L, Kranzler HR. Empirically derived subtypes of opioid use and related behaviors. Addiction (Abingdon, England). 2011 Jun 1; 106(6):1146-54.
  419. Lewis ET, Trafton JA. Opioid use in primary care: asking the right questions. Current Pain and Headache Reports. 2011 Apr 1; 15(2):137-43.
  420. Macey TA, Morasco BJ, Duckart JP, Dobscha SK. Patterns and Correlates of Prescription Opioid Use in OEF/OIF Veterans. Poster session presented at: VA National Pain Management Conference; 2011 Mar 2; Jacksonville, FL.
  421. Krebs EE, Lurie JD, Fanciullo G, Tosteson TD, Blood EA, Carey TS, Weinstein JN. Predictors of long-term opioid use among patients with painful lumbar spine conditions. The journal of pain : official journal of the American Pain Society. 2010 Jan 1; 11(1):44-52.
  422. Hudson TJ, Edlund MJ, Steffick DE, Tripathi SP, Sullivan MD. Epidemiology of regular prescribed opioid use: results from a national, population-based survey. Journal of pain and symptom management. 2008 Sep 1; 36(3):280-8.
  423. Friedly J, Nishio I, Bishop MJ, Maynard C. The relationship between repeated epidural steroid injections and subsequent opioid use and lumbar surgery. Archives of physical medicine and rehabilitation. 2008 Jun 1; 89(6):1011-5.
  424. Pletcher MJ, Kertesz SG, Sidney S, Kiefe CI, Hulley SB. Incidence and antecedents of nonmedical prescription opioid use in four US communities. The Coronary Artery Risk Development in Young Adults (CARDIA) prospective cohort study. Drug and Alcohol Dependence. 2006 Nov 8; 85(2):171-6.
  425. Sullivan MD, Edlund MJ, Zhang L, Unützer J, Wells KB. Association between mental health disorders, problem drug use, and regular prescription opioid use. Archives of internal medicine. 2006 Oct 23; 166(19):2087-93.
  426. Wu SM, Compton P, Bolus R, Schieffer B, Pham Q, Baria A, Van Vort W, Davis F, Shekelle P, Naliboff BD. The addiction behaviors checklist: validation of a new clinician-based measure of inappropriate opioid use in chronic pain. Journal of pain and symptom management. 2006 Oct 1; 32(4):342-51.
  427. Fillingim RB, Doleys DM, Edwards RR, Lowery D. Clinical characteristics of chronic back pain as a function of gender and oral opioid use. Spine (Philadelphia, Pa. : 1986). 2003 Jan 15; 28(2):143-50.

Questions about the HSR website? Email the Web Team

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.